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ABSTRACT
Transient receptor potential canonical 6 (TRPC6) channels are permeable to Na+ and
Ca2+ and are widely expressed in the brain. In this study, we investigated the role of
TRPC6 following ischemia/reperfusion (I/R) and oxygen-glucose deprivation (OGD). We
found that TRPC6 expression was increased in wild type (WT) mice cortical neurons
following I/R and in primary neurons with OGD, and that deletion of TRPC6 reduced the
I/R-induced brain infarct in mice and the OGD- /neurotoxin-induced neuronal death.
Using live-cell imaging to examine intracellular Ca2+ levels ([Ca2+]i), we found that OGD
induced a significant higher increase in glutamate-evoked Ca2+ influx compared to
untreated control and such an increase was reduced by TRPC6 deletion. Enhancement
of TRPC6 expression using AdCMV-TRPC6-GFP infection in WT neurons increased
[Ca2+]i in response to glutamate application compared to AdCMV-GFP control. Inhibition
of N-methyl-d-aspartic acid receptor (NMDAR) with MK801 decreased TRPC6dependent increase of [Ca2+]i, indicating that such a Ca2+ influx was NMDAR
dependent. Furthermore, TRPC6-dependent Ca2+ influx was blunted by blockade of Na+
entry. Finally, OGD-enhanced Ca2+ influx was reduced, but not completely blocked, in
the presence of voltage dependent Na+ channel blocker tetrodotoxin (TTX) and dl‐α‐
amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) blocker CNQX.
Altogether, we concluded that I/R-induced brain damage was, in part, due to
upregulation of TRPC6 in cortical neurons. We postulate that overexpression of TRPC6
following I/R may induce neuronal death partially through TRPC6-dependent Na+ entry
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which activated NMDAR, thus leading to a damaging Ca2+ overload. These findings may
provide a potential target for future intervention in stroke-induced brain damage.
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that is associated
with many cardiovascular complications, such as autonomic dysfunctions, stroke and
heart failure. Chronic intermittent hypoxia (CIH) is a prominent feature of OSA. In CIH
exposed rodents (a model for OSA), CIH induces the similar cardiovascular
complications as seen in OSA patients. In particular, OSA impairs baroreflex control of
the heart rate (HR), which is used as an independent indicator for heart failure. Since
the baroreflex control arc includes the aortic depressor nerve (ADN), vagal efferent and
central components, we hypothesize that CIH induces dysfunctions of all three
components. Since mice can be genetically manipulated, an understanding of the
effects of CIH on multiple neural components in the baroreflex arc in wild type mice may
lead to a future study of treatments. In this study, we have examined the effects of CIH
on baroreceptor afferent, central and vagal efferent components of the baroreflex
circuitry in normal wild type C57BL/6J mice. Mice (4-5 months) were exposed to room
air (RA) or CIH for 35-50 days and were then anesthetized with isoflurane, ventilated
and catheterized for measurement of mean arterial blood pressure (MAP) and HR.
Baroreceptor function was characterized by measuring percent changes of integrated
ADN activity (Int ADNA) relative to the baseline value in response to the vasodilator
sodium nitroprusside and the vasoconstrictor phenylephrine-induced changes in MAP.
Data were fitted to a sigmoid logistic function curve. HR responses to electrical
stimulation of the left ADN and the right vagus nerve were assessed under anesthesia.
iv

Compared with RA controls, CIH significantly increased maximum baroreceptor gain or
maximum slope, maximum Int ADNA, and Int ADNA range (maximum-minimum Int
ADNA). In addition, CIH maintained the maximum amplitude of the bradycardic
response to vagal efferent stimulation. In contrast, CIH significantly reduced the
maximum amplitude of bradycardic response to left ADN stimulation. Thus, CIH
decreased central mediation of the baroreflex, but augmented the baroreceptor afferent
function and maintained vagal efferent control of HR in mice.
Excessive reactive oxygen species (ROS) (such as the superoxide radical) is commonly
associated with cardiac autonomic dysfunctions. Though superoxide dismutase 1
(SOD1) overexpression may protect against ROS damage to the autonomic nervous
system, superoxide radical reduction may change normal physiological functions.
Previously, we demonstrated that human SOD1 (hSOD1) overexpression did not
change baroreflex bradycardia and tachycardia, but increased aortic depressor nerve
activity (ADNA) in responses to arterial pressure changes in C57B6SJL-Tg (SOD1)2
Gur/J mice. Since the barorelfex arc includes afferent, central and efferent components,
the objective of this study was to determine whether hSOD1 overexpression alters the
central and vagal efferent mediation of the heart rate (HR) responses. Our data indicate
that SOD1 overexpression decreased HR responses to vagal efferent nerve
stimulations but did not change HR responses to aortic nerve stimulation. Along with the
previous study, we suggest that SOD1 overexpression preserves the normal baroreflex
function but may alter the functions of aortic depressor nerve, vagal efferent and central
components differently. While SOD1 overexpression likely enhanced aortic depressor
v

nerve function and central mediation of bradycardia, it decreased vagal efferent control
of HR. Currently, we are using the hSOD1 overexpressing mouse model to determine
whether hSOD1 overexpression can preserve normal afferent, efferent, and central
components of the baroreflex arc in the CIH model of sleep apnea.
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INTRODUCTION
This dissertation started with three complete and independent projects as introduced
below. However, they follow the common theme: How do Oxygen-glucose deprivation
(OGD), chronic intermittent hypoxia (CIH), and human copper/zinc (Cu/Zn) superoxide
dismutase (hSOD1) affect the central or peripheral nervous system, and can deletion of
TRPC6 or hSOD1 overexpression protect against diseases-induced neural deficits and
dysfunctions.
The first study is presented in Chapter 1 which is entitled as Deletion of
TRPC6 attenuates MNDA receptor-mediated Ca2+ entry and Ca2+ induced
neurotoxicity following cerebral ischemia and Oxygen-glucose deprivation.
Stroke is the fourth leading cause of death annually in the United States and is the one
of the factors resulting in permanent deficits worldwide. Ischemic stroke is one of the
two main kinds of stroke, due to lack of blood flow. A critical deficit of cerebral blood
flow during stroke rapidly triggers neuronal depolarization that releases a large amount
of glutamate into the extracellular space (Drejer et al., 1985; Choi et al., 1990; Choi,
1992). Oxygen and glucose deprivation (OGD) that is a well-established in vitro model
of ischemia (Tasca et al. 2015). Over-stimulation of glutamate receptors is considered
as a primary intracellular event that induces neuronal death in stroke. Also, abnormal
high level of intracellular Ca2+ concentration ([Ca2+]i) resulting from the massively
glutamate release is known as the cause of a delayed neuronal cell death in OGD
model (Caldeira et al. 2014). Therefore, NMDA receptor (NMDAR) antagonist shown its
1

dramatic neuroprotective effects by againsting Ca2+ uptake in animal and cellular
models (Choi et al., 1988; Chen et al., 1992; Goldberg and Choi, 1993). However,
clinical trials aimed at reducing ischemic brain injury by targeting NMDA receptors,
failed to achieve satisfactory effects (De Keyser et al., 1999; Gladstone et al., 2002; Lo
et al., 2003). Thus, developing new, potential drug targets for the treatment of strokes
could provide a noval perspective in this field (Roth and Liesz, 2016).
More recent studies have indicated the existence of other routes of ionic entry and
imbalance within the injured neurons, such as involving the transient receptor potential
(TRP) family, in particular, the TRP family, canonical subfamily of TRP proteins (TRPC)
subfamily is also permeable to Na+ and Ca2+ non-selectively (Eder et al., 2005; Bush et
al., 2006). The TRPC family is comprised of seven different channels (TRPC1-TRPC7)
that are broadly expressed (Khairatkar-Joshi et al., 2015; Ong et al., 2016). Among
them, several TRPCs (TRPC1, 3, 4, 5, and 6) are expressed in the nervous system and
play roles in neuronal growth, path finding, and differentiation (Montell et al., 2002;
Riccio et al., 2002). TRPCs play a prominent role in fundamental cellular events ranging
from transcriptional regulation to cell proliferation and death (Brinbaumer et al., 1996;
Montell et al., 2002). In particular, TRPC6 is a member of the TRPC subfamily. TRPC6
channels are non-selective cation channels that are permeable to Na+ and Ca2+.
Though many aspects of the physiology and regulation of TRPC6 are still elusive, an
increasing number of important pathological conditions are now being linked to TRPC6
dysfunctions (Dietrich and Gudermann, 2014). TRPC6 channels are localized at the
excitatory synapses and may regulate neuronal excitability (Zhou et al., 2008).
2

Activation of TRPC6 channels is not dependent upon depolarization (Montell et al.,
2002; Ramsey et al., 2006). Since TRPC6 channels are permeable to Na + and Ca2+, we
hypothesized that ischemic stroke and OGD may increase TRPC6 expression which
may, in turn, activate MNDA receptors (NMDAR) and enhance Ca2+ influx. Thus,
deletion of TRPC6 would be expected to reduce ischemia-induced brain damage and
OGD-/glutamate-induced cortical cell death. Our study has demonstrated that TRPC6mediated Ca2+ influx enhanced excitotoxicity by facilitation of NMDAR activation
andTRPC6 deletion attenuated stroke and OGD-induced neuronal death.
The second study is presented in Chapter 2 which is entitled as Effects of
chronic intermittent hypoxia (CIH) on baroreflex control of heart rate in mice:
aortic depressor afferent, vagal efferent and central components.
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder caused by fall in
oxygen saturation in arterial blood (Young et al., 2002). OSA is associated with many
cardiovascular diseases including impaired baroreflex control of heart rate and stroke.
Baroreflex sensitivity (BRS) is considered as a diameter to display the strength of the
baroflex control of heart rate (HR) response to the change on blood pressure (BP).
Impairment of BRS is closely linked to heart failure (Ford et al., 1999; La Rovere et al.,
2000; Shi et al., 2000) and is widely cited as an important risk factor for sudden death
(Jouven et al., 2005).
Chronic intermittent hypoxia (CIH) is one of the characteristics of OSA. CIH has been
used as a useful model to study OSA (Gozal et al., 2001; Kline 2010). Recent studies
3

observed that baroreflex control of HR is significantly reduced after CIH in SpragueDawley (SD) rats (Lai et al., 2006) and different components of barorefelx arc is altered
differently (Gu et al., 2007). However, the mechanisms for CIH-induced baroreflex
impairment are not well studied. Because mice can be genetically manipulated, an
understanding of the effects of CIH on multiple neural components in the baroreflex arc
in wild type mice may lead to a future study of genetic treatments. Therefore, improved
understanding of sleep apnea-associated functional alteration of the neural components
at multiple sites within the baroreflex pathway is important. This systematic study may
provide the background for the genetic theraputic strategies aimed at reducing the
damage associated with OSA. We hypothesized that similarly to the CIH rat model,
CIH differentially alters aortic depressor nerve function, central mediation of baroreflex
bradycardia and vagal efferent control of the heart rate in mice. Indeed, CIH enhanced
aortic depressor nerve function and vagal efferent control of the heart rate, but
significantly decreased central medication of bradycardia in the murine CIH model.
Thus, we propose that the peripheral nerve functions are enhanced to compensate for
the loss of central functions.
The third study is presented in Chapter 3 which is entitled as Baroreflex
control of heart rate in human SOD1 overexpression mice: Functional changes of
central and vagal cardiac efferent components.
Reactive oxygen species (ROS) is a family of toxic, highly reactive compounds when
oxygen accepts unpaired electrons through both enzymatic and non-enzymatic
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reactions in metabolic processes (Pham-Huy et al., 2008). Most ROS are formed in the
mitochondria as a byproduct of ATP synthesis, and are usually tightly regulated by
endogenous antioxidant enzymes that can convert ROS into less harmful compounds.
An increased levels of ROS in the critical neural components of the baroreflex arc
including the carotid and aortic baroreceptors and nucleus tractus solitarus (NTS) are
seen in pathological conditions such as sleep apnea, hypertension, and heart failure
(Hirooka et al., 2008; Zhang et al., 2009; Peng et al., 2012; Li, 2013; Ding et al., 2009;
Tsai et al., 2013). On the other hand, ROS are also critical to cellular signaling (Forman
et al., 2010; Fukai et al., 2011) and defense against infections (Yang et al., 2013;
Nathan et al., 2013) as well. Superoxide dismutases (SOD) enzymes are one of the
most important antioxidant enzymes and acts as the first line of defense against ROS.
SOD1 enzyme could catalyze the reduction state of the superoxide anion (O2 .-) to
hydrogen peroxide (H2O2), subsequently convert into water or oxygen. Recent
researches suggest that antioxidant therapy can restore normal baroreflex function in
some diseases by decreasing levels of ROS locally (Zhang et al., 2009; Peng et al.,
2012) or systemically (Gouty et al., 2003; Wei et al., 2009; Kawada et al., 2014).
However, the available evidence from the literature has suggested that SOD1
overexpression can have detrimental effects on tissues (Kotulska et al., 2006; Jaarsma
et al., 2000; Dal Canto and Gurney, 1995). Therefore, we need to consider whether
hSOD1 overexpression in animals can affect the neural components of the baroreflex
loop in healthy animals. Only then, we can consider any potential benefits of SOD1
overexpression in disease-induced impairment of baroreflex arc. Previously, we have
5

determined the effects of hSOD1 overexpression in transgenic mice on several
physiological variables [arterial pressure (AP), heart rate (HR), BRS, and aortic
depressor nerve function] compared to controls. Our previous data indicated that
hSOD1 overexpression in transgenic mice did not alter the values of AP, HR, and
baroreflex sensitivity but enhanced aortic depressor nerve function. Baroreflex arc
includes vagal aortic depressor nerves, central components [e.g., the nucleus of the
solitary tract (NTS), and vagal motor nucleus], and vagal efferent nerves. Since hSOD1
overexpression enhances aortic depressor nerve function but maintained baroreflex
sensitivity, we hypothesized that hSOD1 overexpression may alter the central
mediation and/or vagal efferent control of HR. Indeed, SOD1 overexpression enhanced
central medication of bradycardia, but decreased vagal efferent control of HR. Along
with our previous study, the present work will provide baseline data on effect of the
hSOD1 overexpression on the multiple components within the baroreflex arc which will
facilitate future studies on the possible protective effects of overexpressed SOD1 in
murine disease models.

6

CHAPTER I: DELETION OF TRPC6 ATTENUATES NMDA
RECEPTOR-MEDIATED CA2+ ENTRY AND CA2+-INDUCED
NEUROTOXICITY FOLLOWING CEREBRAL ISCHEMIA AND
OXYGEN-GLUCOSE DEPRIVATION

Chapter I: Introduction
Ischemic stroke is a devastating disease that is one of the leading causes of death. A
critical deficit of cerebral blood flow during stroke rapidly triggers neuronal
depolarization that releases a large amount of glutamate into the extracellular space
(Drejer et al., 1985; Choi et al., 1990, 1992). Glutamate binds to and activates dl-αamino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors and N-methyld-aspartic acid (NMDA) receptors (McLennan, 1983; Choi, 1988a, b). Overactivation of
the AMPA and NMDA receptors opens their associated ion channels to produce an
increased influx of Na+ and Ca2+, leading to an ionic imbalance within neurons (Choi,
1993; Arundine and Tymianski, 2004). Ca2+ overload has been shown to be related to
Na+ entry (Yu and Salter, 1998; Yu, 2006). It is well established that the loss of
homeostasis of Na+ and Ca2+ plays an important role in ischemia-induced neuronal
damage (Breder et al., 2000; Bano and Nicotera, 2007). Thus, over-stimulation of
glutamate receptors can be considered as a primary intracellular event that induces
neuronal death in stroke. Likewise, upon oxygen and glucose deprivation (OGD) that is
a well-established in vitro model of ischemia (Tasca et al. 2015) , glutamate is
massively released by neurons, and the resulting increase in the intracellular Ca2+
7

concentration ([Ca2+]i) causes a delayed neuronal cell death (Caldeira et al. 2014).
Therefore, treatments by blocking glutamate-ionotropic receptors can protect neurons
from ischemic insult and reduce brain infarction in animals (Choi et al., 1988a; Chen et
al., 1992). Similarly, Ca2+ uptake and neuronal cell death following OGD can also be
prevented by the NMDA receptor (NMDAR) antagonist (Goldberg and Choi, 1993).
Though the blockade of glutamate receptors shows dramatic neuroprotective effects in
animal stroke and in vitro OGD models, clinical trials aimed at reducing ischemic brain
injury by targeting NMDA and AMPA receptors, failed to achieve satisfactory effects (De
Keyser et al., 1999; Gladstone et al., 2002; Lo et al., 2003). Therefore, there is a great
need to develop new, potential drug targets for the treatment of strokes (Roth and Liesz,
2016).
More recent studies have indicated the existence of other routes of ionic entry and
imbalance within the injured neurons, such as involving the transient receptor potential
(TRP) family, in particular, the melastatin subfamily of TRP proteins (TRPM). TRPM7 is
a well-studied protein among this subfamily which has been shown to be linked with
ischemia injured neurons (Aarts and Tymianski, 2005). TRPM7 is a non-selective cation
channel that conducts both monovalent ions (Na+ and K+) and divalent ions (Ca2+, Mg2+
and other trace metal ions) (Bae and Sun, 2011). TRPM7 channels have been reported
as an essential mediator of anoxic neuronal death due to its Ca2+-permeable,
nonselective cation channel characteristics (Aarts et al. 2003; MacDonald and Jackson,
2007). Suppression of hippocampal TRPM7 channels could prevent neuronal death in
brain ischemia (Sun et al., 2009). Carvacrol, acting as a TRPM7 inhibitor, protects brain
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from neonatal hypoxic-ischemic injury (Chen et al., 2015). Thus, TRPM7 becomes a
promising therapeutic target for stroke treatment (Bae and Sun, 2011; Bae and Sun,
2013).
The other member of the TRP family, canonical subfamily of TRP proteins (TRPC)
subfamily is aalso permeable to Na+ and Ca2+ non-selectively (Eder et al., 2005; Bush
et al., 2006). The TRPC family is comprised of seven different channels (TRPC1TRPC7) that are broadly expressed (Khairatkar-Joshi et al., 2015; Ong et al., 2016).
Among them, several TRPCs (TRPC1, 3, 4, 5, and 6) are expressed in the nervous
system and play roles in neuronal growth, path finding, and differentiation (Montell et al.,
2002; Riccio et al., 2002). TRPCs play a prominent role in fundamental cellular events
ranging from transcriptional regulation to cell proliferation and death (Brinbaumer et al.,
1996; Montell et al., 2002). In particular, TRPC6 is a member of the TRPC subfamily.
Similar to TRPM7, TRPC6 channels are non-selective cation channels that are
permeable to Na+ and Ca2+. Though many aspects of the physiology and regulation of
TRPC6 are still elusive, an increasing number of important pathological conditions are
now being linked to TRPC6 dysfunctions (Dietrich and Gudermann, 2014). TRPC6 has
been shown to contribute to the sustained Ca2+ elevation that is responsible for glioma
proliferation (Bomben et al., 2008; Ding et al., 2010), hypertrophic growth of
cardiomyocytes (Bush et al., 2006; Kuwahara et al., 2006; Nishida and Kurose, 2008;
Onohara et al., 2006), proteinuric kidney disease (Möller et al., 2007) and pulmonary
hypertension (Lin et al., 2004; Weissmann et al., 2006). Activation of TRPC6 was
responsible for lung ischemia-reperfusion induced oedema in mice (Weissmann et al.,
9

2012) and high glucose- or oxidative stress-induced podocyte ischemic injury (Yang et
al., 2013; Zhao et al., 2015) and downregulation of TRPC6 by Klotho showed
cardioprotective effects in the mouse heart (Xie et al. 2012).
TRPC6 channels are localized at the excitatory synapses and may regulate neuronal
excitability (Zhou et al., 2008). Activation of TRPC6 channels is not dependent upon
depolarization (Montell et al., 2002; Ramsey et al., 2006). Since TRPC6 channels are
permeable to Na+ and Ca2+, we hypothesized that ischemic stroke and OGD may
increase TRPC6 expression which may, in turn, activate MNDA receptors (NMDAR)
and enhance Ca2+ influx. Thus, deletion of TRPC6 would be expected to reduce
ischemia-induced brain damage and OGD-/glutamate-induced cortical cell death. Our
study has demonstrated that TRPC6-mediated Ca2+ influx enhanced excitotoxicity by
facilitation of NMDAR activation andTRPC6 deletion attenuated ischemia-induced
neuronal death.

Chapter I: Materials and Methods

Materials.
EBSS (Earle’s Balanced Salt Solution), Hank’s buffer, Glutamax, and
penicillinstreptomycin, Trizol, SuperScript II RNaseH reverse transcriptase and T-PER
buffer were purchased from Invitrogen. GoTaq Green was obtained from Promega.
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Neurobasal medium, B27, Dulbecco’s Modified Eagle Medium (DMEM), and bovine calf
serum were purchased from Hyclone. 2, 3, 5-triphenyltetrazolium chloride (TTC),
propidium iodide (PI), protease inhibitor cocktail, N-methyl-D-glucamine (NMDG) and
Trypan blue were obtained from Sigma. Other reagents include: CNQX, MK801
(Molecular Probes); tetrodotoxin (TTX, Alamone); Fura-2 acetoxymethyl ester (Fura-2
AM, Molecular Probes). Recombinant adenoviruses AdCMV-GFP and AdCMV-TRPC6GFP-Myc-tag were kindly provided by Dr. Christopher B. Newgard. The sources of the
primary antibodies were as following: TRPC6 (Sigma, Lot# 8831P1), MAP2 (Cell
Signaling, #4542), and Beta-Actin (Abcam, ab8227). The goat anti-rabbit and antimouse secondary antibodies conjugated to horse radish peroxidase were from Jackson
Immunoresearch.

Animals
Wild type WT mice (C57 BL/6J) were used as the background to generate TRPC6-/mice. The generation of TRPC6-/- mice has been previously described (Dietrich et al.,
2005). The TRPC6-/- mice have been obtained from Dr. Lutz Birnbaumer (National
Institute of Environmental Health Sciences) and were housed in in the transgenic animal
facility (TAF). One male WT mouse was housed in the same cage with one female WT
mouse. Similarly, one male TRPC6-/- mouse was housed in the same cage with one
female TRPC6-/- mouse. The pregnant mice were separated from the males and kept in
a single cage as soon as they showed signs of pregnancy. The regnant mice were
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checked daily. The animal protocol had been approved by UCF IACUC. All experiments
were conducted in accordance with the recommendations of UCF IACUC.

Mice and Focal Cerebral Ischemia Model
TRPC6-/- and WT control mice were maintained on a 12 h light/12 h dark cycle with food
and water. Three-four month-old male mice were used for this experiment. The focal
cerebral ischemia/reperfusion model was generated following that described previously
(Culmsee et al., 2001, Arumugam et al 2006, Wei et al. 2011). Briefly, mice were
anesthetized with isofluorane (3-4 % mixed with oxygen). The animals were maintained
under anesthetic using an anesthesia machine with a scavenger until the completion of
the surgery. The depth of anesthesia was assessed by the amplitude of the leg twitch in
response to the pinch of the toes. A midline incision was made in the neck, and the left
external carotid and pterygopalatine arteries were isolated and ligated with 5-0 silk
thread. The internal carotid artery (ICA) was occluded with a small clip applied at a site
that was peripheral to the bifurcation of the internal carotid artery (ICA) and the
pterygopalatine artery. The common carotid artery (CCA) was ligated with 5-0 silk
thread. The external carotid artery (ECA) was cut, and the tip of a 6-0 nylon
monofilament was inserted into the ECA. After the clip at the ICA was removed, this
nylon thread was advanced into the middle cerebral artery (MCA) until light resistance
was felt. The nylon thread and the CCA ligature were removed after 60 minutes of
occlusion to initiate reperfusion. Cerebral blood flow (CBF) was measured using a laser
Doppler perfusion monitor and all CBF measurements were conducted with the mouse
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fixed in a plastic frame with the probe placed in the region of cerebral cortex perfused
by the MCA as previously described (Arumugam et al. 2006). All surgical instruments
were autoclaved prior to use. The animals were placed on a heating pad during the
surgery and recovery from anesthesia, during which time the animals were be closely
monitored. Postoperative pain was relieved using buprenorphine (0.03 mg/kg body
weight; IP). Analgesia was given post-op prior recovery from anesthesia and then every
12 hours for 2 days. The animals were euthanized at various time points (12 h, 18 h, 24
h, 48 h, 72 h after the surgery), and the ipsilateral and contralateral cortices of their
brains were removed for immunohistochemical and biochemical analyses.

Quantification of cerebral infarction
After 24 hours of reperfusion, the mice were euthanized with isofluorane (5 % mixed
with oxygen). The brains were immediately removed and placed into ice-cold PBS for
15 min, and then 2-mm coronal sections were cut. The brain sections were stained with
TTC (2 %) in PBS at 37°C for 15 min. The stained sections were photographed, and the
digitized images were used for analysis. The borders of the infarct in each brain slice
were outlined, and the area quantified using an ImageJ software. Infarct volume was
calculated by integration of infarct areas for all slices of each brain (Arumugam et al.,
2006, Tu et al. 2010, Pei et al. 2015).
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Primary Cortical Neuronal Cultures
Primary cultures of mouse cortical neurons were prepared from the 18-day-old fetuses
of pregnant female mice as previously described (Brewer et al., 1993; Brewer, 1997;
Szychowski et al., 2015). Briefly, brain cortices were harvested by removal of the
brainstem and hippocampus followed by mechanical trituration. After the dissected
tissue was minced and gently digested with trypsin, the cells were suspended in
Neurobasal medium (Gibco) supplemented with 2% B-27 supplement (Invitrogen), 2
mM glutamax, and 1% antibiotic (50 U/mL penicillin, and 0.05 mg/mL streptomycin).
This procedure typically yields cell cultures that contain about 90 % neurons and 10 %
astrocytes (Kajta et al., 2004). Live cells were identified using Typan blue staining and
counted. The cells were seeded at a density of 5×105 cells per well in 6-well plate (all
plates were pre-coated with poly-D-lysine) and maintained at 37°C with 5 % CO2. Half
of the medium was changed every 3 days, and the cells were cultured for 14-16 days.

Oxygen Glucose Deprivation
After 14-16 days of culture, the primary cortical neurons were challenged with oxygenglucose deprivation (OGD) (Goldberg and Choi, 1993). OGD was induced by washing
and incubating the cultures in a pre-equilibrated glucose-free balanced salt solution in
the Billups-Rothenberg anaerobic chamber containing 95 % nitrogen and 5 % CO2. The
chamber was sealed and incubated for 2 h at 37 °C. At the end of the procedure, culture
medium was removed and replaced with serum-containing Neurobasal medium prior to
returning the neuronal cultures to normoxia (95 % oxygen and 5 % CO2) for 24 h.
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Control cultures were incubated for 2 h in a similar balanced salt solution containing 5.5
mM glucose under normoxic conditions.

RT-PCR
Total RNA was extracted from the ipsilateral and contralateral cortices of the brain
tissue using Trizol reagent following the manufacture’s protocol. Reverse transcription
was started with 2 μg of total RNA at 42 ºC for 60 min in 20 μL reaction mixture
containing 20 U RNase inhibitor, 0.25 mM of each dNTP, 0.5 μg Oligo(dT)15, 200 U
SuperScript II RNaseH reverse transcriptase. Synthesized first-strand cDNA was then
amplified by PCR in 25 μL reaction volume, containing 5 μL DNA template, 12.5 μL
GoTaq Green Master Mix, a pair of primer for TRPC6 and inner control β-actin,
respectively (10 pmol per primer). An appropriate cycle number was chosen to avoid the
accumulation of by-products and yield accurate replication of target DNA before the
characteristic plateau phase was reached in the PCR amplification curve. PCR
procedure included: pre-denatured at 95 ºC for 5 min; amplification at 95 ºC 50 s, 56 ºC
1 min, 72 ºC 1 min; and extended at 72 ºC for 10 min. Aliquots of the PCR product were
separated using agarose gel electrophoresis and visualized with ethidium bromide
staining. The following oligonucleotide primers were used: for TRPC6, sense 5’-CAG
ATC ATC TCT GAA GGT CTT TAT GC-3’ and anti-sense 5’-TGT GAA TGC TTC ATT
CTG TTT GCG CC-3’; for β-actin, sense 5’-TGC TAT CCC TGT ACG CCT CT-3’, antisense 5’-GGA GGA GCA ATG ATC TTG A-3’.

15

Western Blot
Protein from ipsilateral and contralateral cortices was extracted using T-PER tissue
protein extraction buffer with protease inhibitor cocktail (Sigma). Protein concentration
was determined using the BCA protein assay kit (Pierce, USA). Fifty μg of protein was
separated by SDS-PAGE (8-12%) and transferred to nitrocellulose membranes. The
membranes were blocked in 5% nonfat milk for 1 h at room temperature, followed by an
overnight incubation at 4 °C with antibodies raised against TRPC6 or β-actin.
Membranes were then washed and incubated with secondary antibodies for 1 h at room
temperature. Protein bands were visualized using a chemiluminescence detection kit
(Amersham Biosciences).

Adenovirus infection
For adenovirus construction, cytomegalovirus (CMV) promoter-driven human
Myctagged TRPC6 adenovirus was constructed by cloning cDNA constructs into the
pAdTrack shuttle vector and using the Ad-Easy system to generate the recombinant
adenoviruses as previously described (He et al., 1998; Hayes et al., 2013).
Approximately 14-16 days after cortical neuron seeding, the medium was removed and
cells were transduced at viral doses of up to 20 pfu/cell for 4 h (Robert et al., 1997).
After the virus-containing medium was removed, the fresh medium was added. At 24-h
intervals, cells were collected for the experiments.
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Quantification of Neuronal Death
Propidium iodide (PI) staining of nuclei (red) in primary neurons from WT and TRPC6 -/mice following OGD, 100 μM glutamate or 50 μM NMDA pretreatment were performed.
Primary neuron cells were fixed with cold 70% ethanol, permeabilized with 0.5% Triton
X-100 in PBS for 5 min and RNase treated (100 U/ ml; Sigma ) at room temperature for
120 min. Nuclei were stained with 1μg/ml propidium iodide (PI; Sigma) for 10 min (Ito et
al. 2004). For double-labeling of the nuclei and cell body with dendrites, nonspecific
sites were blocked with 5% BSA in PBS at room temperature for 60 minutes, and cells
were incubated at 4º C with rabbit MAP2 (Cell Signaling, #4542) overnight after fixation
(Campbell et al. 2014; Soltani et al., 2005). The cells were incubated with Goat antiRabbit IgG (H+L), Alexa Fluor® 488 (Invitrogen) for 60 minutes after three time
washings. Then, nuclei were stained with 1μg/ml propidium iodide (PI; Sigma) for 10
min). Coverslips were mounted with mounting medium containing anti-bleaching agent
and examined with a fluorescence microscope (Nikon 80i). The number of PI-labeled
bright condensed nuclei was counted and expressed as the percentage of the total
number of PI positive cells counted, indicating the percent of cell death. All experiments
were repeated using at least three independent cultures.

Intracellular Ca2+ Imaging
After 14-16 days of culture, these neurons were loaded with the fluorescent dye Fura-2
acetoxymethyl ester (Fura-2 AM) (3 μM) for 30 min in humidified 5% CO2 incubator at
37°C, washed 3 times in HEPES-KRH buffer (116 mM NaCl, 4 mM KCl, 1 mM MgCl2,
17

1.8 mM CaCl2, 25 Mm Glucose, 10 mM HEPES, pH 7.4) and incubated for additional 30
min. Then, the changes in free intracellular Ca2+ concentration ([Ca2+]i) in neurons
loaded with Fura-2 were recorded and measured using the Nikon Live Image System
with Nikon Elements software (Nis-Elements AK 4.13). Images were taken every 10 sec
with an exposure time of 200 msec. Fura-2 dual excitation images were captured with a
camera (AnDor; Fluor 40× objective). The baseline Fura-2 fluorescence intensity
(expressed as the ratio of 340/380 nm) was measured 1 min before glutamate
application. Glutamate application (100 μM) at 60 sec after initiation of recording was
used to evoke Ca2+ influx. An increase in relative Fura-2 340/380 fluorescence indicates
an increase in free intracellular Ca2+ concentration (Hirst et al., 2005; Barreto-Chang
and Dolmetsch, 2009). The fluorescence intensity of primary neurons (ratio of 340/380
nm) in each image frame was normalized relative to the background intensity.
Appropriate regions of interest, representing a change in Ca2+ influx, were selected, and
the average ratio of fluorescence was represented in graphs. The change of
fluorescence intensity (F) of each neuron at the different time points was normalized
relative to the initial intensity (F0) of that neuron at 0 sec (before glutamate application).
The mean dynamic changes in [Ca2+]i were determined at each time point for 3-10
neurons in each experiment.

Statistical Analysis
Values were represented as mean ± S.E.M. Student t-test was used for comparison
between two groups. Statistical comparisons were performed using ANOVA and
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Newman-Keuls post-hoc test for pairwise comparisons. Statistical significance was
accepted at P<0.05.

Chapter I: Results

Ischemia/Reperfusion (I/R) and OGD increased TRPC6 expression.
To determine whether ischemia altered the TRPC6 expression level, we measured
mRNA levels of TRPC6 in the brains following I/R. We found that mRNA expression of
TRPC6 was markedly upregulated, starting at 12 h after I/R in the ipsilateral, but not in
the contralateral cortices (Fig 1A). Analogously to its transcript, TRPC6 protein levels
were significantly higher in the ipsilateral side than in the contralateral cortices (Fig 1B).
TRPC6 protein levels were also measured at 6, 12 and 24 h following OGD in primary
cortical neurons. Immunoblot showed a significant increase of the TRPC6 protein level
in OGD-treated cortical neurons 24 h after OGD treatment (Fig 1C), that was consistent
with the I/R mice as shown in Figure 1B. These results demonstrated that I/R and OGD
induced a significant increase in TRPC6 expression in neurons.
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TRPC6 deletion attenuated I/R-induced brain infarct size and protected neurons from
OGD-induced cell death.
To determine whether TRPC6 plays a role in the brain infarct size, we employed the I/R
model in WT and TRPC6-/- mice. Two days after I/R, we measured the amount of the
brain damage. We found that the infarct size was significantly decreased in the TRPC6 -/mice compared to WT mice (Fig 2A), indicating that TRPC6 deletion rendered the brain
less susceptible to the ischemic insults. To determine whether TRPC6 ablation may
alter physiologic variables that can influence functional outcome in ischemic stroke,
regional cerebral blood flow (rCBF) was measured using a laser Doppler probe as
previously described (Arumugam et al. 2006). rCBF in the area blood-supplied by MCA
was reduced equivalently to near constant values averaging approximately 20% of
normal flow. Upon reperfusion, rCBF recovered both in WT and TRPC6-/- mice. Hence,
TRPC6 ablation does not affect rCBF before, during, or after ischemia (Fig 2A).
To examine whether TRPC6 plays a role in OGD-induced neuronal cell death, we
challenged WT and TRPC6-/- cortical neurons with OGD. Cell viability was assessed by
PI staining (red) that had bound to the nucleotide. The dying neurons had the smaller
size of nuclei (<2 μM in diameter) than the other neurons that have the normal size of
nuclei (4-5 μM) (Hezel et al., 2012). Compared to WT neurons challenged with OGD,
there were significantly fewer condensed PI-labeled nuclei in TRPC6-/- neurons in the
same condition (Fig 2B Left, Red). To further identify neurons, we used the neuronspecific marker MAP2 to label cell body and dendrites (Fig 2B Left, Green). PI and
MAP2 double-labeling of neurons with and without OGD pretreatment were shown in
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Figure 2B Left. These data showed that deletion of TPRC6 significantly reduced the
OGD-induced neuronal cell death (as indicated by the bright shrinking nuclei and lack of
MAP2).

TRPC6-/- protected against glutamate or NMDA-induced cell death.
To evaluate the role of TRPC6 in excitotoxic neuronal death, we treated WT and
TRPC6-/- cortical neuron cultures (14-16 days) with glutamate (100 μM) and NMDA (50
μM) for 30 min, respectively. Twenty-four hours after glutamate or NMDA treatment, the
cultured neurons were fixed and cell viability was assessed by PI staining (red). These
results showed that glutamate and NMDA significantly increased neuronal cell death
compared to normal untreated neurons. Deletion of TRPC6 significantly protected
neurons from glutamate and NMDA-induced cell death (Fig 3A, 3B, 3C).

OGD increased Ca2+ influx in response to glutamate and TRPC6 deletion decreased
OGD induced Ca2+ overload.
Because Ca2+ overload is one of the major contributors to OGD-induced neuronal cell
death (Goldberg and Choi, 1993; Bruno et al., 1994; Honda et al., 1994), we next
determined whether TRPC6 deletion protects against OGD -induced Ca2+ influx. Figure
4A included original recordings of intracellular Ca2+ level [Ca2+]i at different time frames
in response to glutamate application at 60 s after the start of recording (0 sec) into the
bath. Figure 4B and Figure 4C showed the time course and the peak of [Ca2+]i in
response to glutamate application, respectively. OGD pretreatment significantly
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increased [Ca2+]i in neurons in both WT and TRPC6-/- neurons compared to the [Ca2+]i
level at the start of recording (0 Sec) where F/F0 equaled 1. Deletion of TRPC6
significantly attenuated OGD-induced [Ca2+]i increase compared to control (P<0.01).
These observations indicate that TRPC6 contributes to OGD-increased Ca2+ influx.

Ca2+ influx was enhanced in TRPC6 overexpressed neurons, independent of AMPA
receptors.
To demonstrate whether TRPC6 could mediate Ca2+ influx and whether such an influx
was dependent on AMPA channel receptors whose opening also increased the opening
probability of NMDA receptor channels (see below), WT cortical neurons were infected
for 4 hours with AdCMV-TRPC6-GFP to overexpress TRPC6 and AdCMV-GFP as
control (normal TRPC6 expression). Twenty-four hours after infection, neurons showed
GFP (green) (Fig 5A last column) to confirm the successful infection. Glutamate (100
M) was applied to a bath containing infected neurons in the presence of the AMPA
antagonist CNQX (10 M) that could effectively block AMPA receptors on the
glutamate-induced [Ca2+]i elevation (Dixon and Copenhagen, 1992; Regan and Choi,
1994). Different from the control group where the intracellular Ca2+ level peaked at 60
sec, [Ca2+]i was enhanced in response to glutamate over the whole recording period
(300 sec) in TRPC6 overexpressed neurons. In the presence of CNQX, overexpression
of TRPC6 still enhanced [Ca2+]i in response to glutamate application, indicating TRPC6
could mediate Ca2+ influx in response to glutamate independent of AMPA receptors (Fig
5B).
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TRPC6 overexpression-induced [Ca2+]i increase was attributed to NMDAR activation.
To determine whether the glutamate-evoked Ca2+ influx increase observed in TRPC6infected neurons was attributable to NMDAR activation, we applied NMDAR antagonist
MK-801. WT cortical neurons were infected with AdCMV-TRPC6-GFP to enhance
TRPC6 expression and AdCMV-GFP for control. Glutamate (100 M) was applied to a
bath containing infected neurons in the presence of MK-801 (20 M) which could
effectively block NMDAR receptor mediated-, glutamate-induced [Ca2+]i increases
(Wong et al, 1986; Tasker et al., 1992). After glutamate application, [Ca2+]i was evoked.
TRPC6 overexpression significantly increased glutamate evoked [Ca2+]i compared to
the control but MK-801 reduced such an increase (Fig 5C). Thus, TRPC6
overexpression induced the glutamate evoked [Ca2+]i elevation that is largely attributed
to NMDAR activation.

Glutamate-evoked [Ca2+]i increase observed in TRPC6-overexpressed neurons was
attributed to NMDAR activation.
To determine whether the glutamate-evoked [Ca2+] influx increase observed in TRPC6infected neurons is attributable to NMDAR activation, we applied NMDAR antagonist
MK-801 (Tasker et al., 1992) during [Ca2+]i detection. WT cortical neurons were infected
with AdCMV-TRPC6-GFP (TRPC6-GFP) to enhance TRPC6 expression and AdCMVGFP (GFP) for control (normal TRPC6 expression). 24 hours after infection, neurons
showed GFP (green) in Figure 6A (the last column) to demonstrate successful
infection. 100 M glutamate was applied to a bath containing infected neurons in the
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presence of the NMDAR antagonist (20 M, MK-801) which could effectively block
NMDAR receptors on the glutamate-induced [Ca2+]i increase. Figure 6A show the
ratiometric fluorescence images before and after glutamate application in control (GFP)
and TRPC6-infected neurons, respectively. Figure 6A first and third rows and Figure
6A second and fourth rows show the ratiometric fluorescence images of control and
TRPC6-infected neurons without and with MK-801 treatment, respectively. After
glutamate application, intracellular [Ca2+]i was evoked. TRPC6 overexpression
significantly increased glutamate evoked intracellular [Ca2+]i, but MK-801 abolished
such an increase in TRPC6-infected neurons. Thus, glutamate-induced [Ca2+]i increase
observed in the TRPC6-infected neurons is significantly attributed to NMDAR activation.

TRPC6 overexpression-mediated [Ca2+]i increase was attributed to Na+ entry.
Na+ influx regulates neuronal excitability and is responsible for the initiation and
propagation of action potentials (Yu et al., 1998). NMDA receptor-mediated Ca2+ influx
can be enhanced by raising intracellular Na+ ([Na+]i) or activating Na+-permeable
channels (Taylor and Meldrum, 1995; Yu et al., 2006). To determine whether the activity
of NMDAR may be regulated by TRPC6 via the actions of Na+ entering neurons, we
examined glutamate-evoked Ca2+ levels in TRPC6 overexpressed neurons by
completely eliminating Na+ in the culture medium. Na+ was replaced by the large
membrane-impermeable cation N-methyl-D-glucamine (140 mM NMDG replacing 140
mM NaCl) in the bath solution such that the electrical charges and osmolality across the
cell membrane would not be changed (Storozhevykh et al., 1998). Again, WT cortical
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neurons were infected with AdCMV-TRPC6-GFP to enhance TRPC6 expression and
infected with AdCMV-GFP as control. After 24 hours infection, [Ca2+]i was significantly
enhanced in TRPC6 overexpressed neurons compared to control group (GFP) in
response to glutamate application. NMDG replacement significantly, but not completely,
reduced such an increase in TRPC6-infected neurons (Fig 5D). Thus, the glutamateevoked increase in [Ca2+]i was significantly reduced in TRPC6 overexpressed neurons
in Na+-free bath, suggesting that TRPC6 induced [Ca2+]i increase was, at least partially,
attributed to Na+ entry to the neurons.

OGD-induced [Ca2+]i increase may be attributed to voltage-sensitive Na+ channels and
AMPA receptor channels.
As shown in Figure 4, TRPC6 mediated Ca2+ entry following OGD. We further assessed
whether OGD-induced increase in [Ca2+]i was also mediated by other channels, e.g.,
voltagesensitive Na+ channels and AMPA receptor mediated channels, voltage-sensitive
Na+ blocker Tetrodotoxin (TTX, 0.1 μM) was applied to block voltage-sensitive Na+
channels in the presence of AMPA receptor blocker CNQX (10 μM) (Taker et al., 1992;
Glazenr et al., 2000; Tu et al., 2009). The Ca2+ influx in response to glutamate
application was measured in WT cortical neurons with OGD pretreatment in presence of
TTX and CNQX, along with WT cortical neurons with or without OGD. OGD induced
[Ca2+]i increase was significantly reduced, but not completely eliminated by TTX/CNQX
in neurons compared to the control neurons (WT) (Fig 6). In addition to TRPC6 voltageinsensitive channels that contributed OGD-enhanced Ca2+ influx, voltage-sensitive Na+
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channels or/and AMPA receptors may contribute to OGD-enhanced Ca2+ influx. This
indicates that Na+ entry via TRPC6, voltage-sensitive Na+ channels and AMPA receptor
channels all play a role in facilitating depolarization-induced NMDAR activation during
OGD.

Chapter I: Discussion and Colusion
For decades, Ca2+ overload has been considered as one of the major mechanisms
underlying ischemia-induced neuronal death. Blockers of NMDA receptors were used to
reduce Ca2+ influx and showed protective effects on the brain damages in animal stoke
models. Unfortunately, multiple clinical trials of glutamate antagonists failed to show
effective neuroprotection and had serious side effects in stroke patients (Roth et al.,
2016). There is an urgent need to develop new, effective alternative targets for
treatment. Here, the present study reports that deletion of TRPC6 protects against
cerebral I/R-induced brain damage in vivo and OGD- and excitatory neurotoxin-induced
cell death in vitro. This protection is mediated, in part, through the TRPC6 mediated
NMDA receptors. Specifically, TRPC6 expression was increased in the brain tissues in
the I/R animal model and OGD-treated cortical neurons in culture. In addition, deletion
of TRPC6 protected I/R-induced brain damage and OGD-induced neuronal death.
Furthermore, deletion of TRPC6 could also protect neurons against excitatory
neurotoxin (glutamate or NMDA)-induced cell death. To determine the cellular and
molecular mechanism for OGD-induced neuronal death, OGD was found to increase,
26

but deletion of TRPC6 reduced glutamate-evoked Ca2+ entry. TRPC6 overexpression
increased glutamate-evoked Ca2+ entry in the presence of the AMPA blocker, indicating
TRPC6-incrased Ca2+ entry could be independent of AMPA receptor channels. In the
presence of the NMDA receptor antagonist MK801, the increased glutamate-evoked
Ca2+ entry in TRPC6 overexpressed neurons was largely reduced, indicating that NMDA
receptors were involved. To assess whether Na+ contributed to the TRPC6-enhaced
Ca2+ influx, we found that glutamate-evoked Ca2+ entry in TRPC6 overexpressed
neurons was largely reduced in Na+-free bath, indicating that Na+ entry was required for
TRPC6-mediated Ca2+ influx. Finally, we found that glutamate-evoked Ca2+ entry was
reduced but not completely abolished in OGD-treated WT neurons after blockade of
voltagesensitive Na+ channels and AMPA receptor channels. We postulate that TRPC6
channels, as well as other channels (e.g., voltage-sensitive Na+ channels), may
contribute to TRPC6-mediated Ca2+ influx, at least in part, through NMDA receptor
channels. Therefore, the present data have demonstrated that overexpression of
TRPC6 may contribute to neuronal death partially through Na+ entry, leading to
activation of NMDA receptors, thus causing an overload of Ca2+.
The present results are consistent with several findings about TRPC6 in different
tissues and organs. Previously, it has been demonstrated that hypoxia could drive
glioblastoma multiforme cells into a more aggressive and malignant state through
Notch1-induced TRPC6 overexpression which in turn activated the calcineurin-nuclear
factor of activated T-cell (NFAT) pathway and increased Ca2+ influx (Chigurapati et al.,
2010). Later, TRPC6-/- mice were found to be resistant to I/R-induced edema in the lung
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(Weissmann et al., 2012). TRPC6-deficient mice attenuated I/R -induced Ca2+ influx,
cellular shape changes, and barrier dysfunction in the lung. Along this line, it has been
further reported that activation of TRPC6-dependent Ca2+ signaling facilitated endotoxininduced lung vascular permeability and inflammation (Tauseef et al., 2012). Moreover,
TRPC6 deletion in mice increased resistance to endotoxin-induced barrier dysfunction
and inflammation, and protected against sepsis-induced lethality. In the kidney,
acquired glomerular diseases were associated with increased expression levels of
TRPC6. It has been reported that overexpression of TRPC6 in podocytes was sufficient
to cause a kidney disease consistent with focal and segmental glomerulosclerosis (Krall
et al., 2010). Though the above studies were from non-neural tissues, they all indicated
that overexpression or activation of TRPC6 was involved in disease-related damages in
tissues and organs.
Consistent with the present finding, TRPC6 expression levels in the retinal ganglion
cells were increased 24 hr after I/R in rats (Wang et al., 2010). Similarly, TPRC6 levels
were increased in patients with glaucoma (Chen et al., 2013). Different from the present
findings, however, activation of TRPC6 before ischemia has been reported to have
neuroprotective effects on retinal ganglion cells (Wang et al., 2010). In contrast, TRPC6
expression levels were decreased in the brain after I/R and activation of TRPC6 had
protective effects on ischemic brain damage in rats (Du et al., 2010). Furthermore,
TRPC6 activator Hyperforin and Resveratrol has been shown to suppress MCAOinduced brain damage via inhibition of TRPC6 degradation in rats (Lin et al., 2013a, b).
Thus far, the exact reasons for these discrepancies among these studies are not
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known. Possibly, different animal models, tissue types, and approaches contributed to
these discrepancies. Whereas other studies used rat models, we used TRPC6 -/- mouse
models. Further investigation is needed to address these discrepancies.
It should be mentioned that TRPC1 or TRPC3 are also widely expressed in the nervous
system and they have structural similarities with TRPC6 (Ricco et al., 2002). In addition
to TRPC6, the expression level of TPRC1 in the brain tissue was measured after I/R in
WT mice and the TRPC3 expression level in the primary cultured neurons following
OGD in the early stage of the present study. In contrast to TRPC6 expression as shown
in Figure 1, expression of TRPC1 was not increased in the ipsilateral cortex after I/R
and TRPC3 expression was not increased in OGD-treated cortical neurons
(unpublished observations). These initial observations lead to the selection of TRPC6,
rather than TRPC1 and TRPC3 in this study. Whether TRPC1 and TRPC3 may be
involved in I/R-induced brain damage should be studied in the future.
In summary, the present studies have demonstrated that TRPC6 overexpression after
I/R and following OGD treatment may contribute to brain damage and to OGD- and
neurotoxicityinduced cell death. Activation of TRPC6 channels may increase Ca2+ influx
through NMDAR, which may lead to cell death. Since TRPC6 channels are voltageindependent and are not involved in the major neurotransmission, pharmacologic
interventions targeting at TRPC6 may potentially have fewer side effects than direct
blockade of NMDAR. Though this study has provided a potential mechanism for
theTRPC6 deletion protection against Ca2+ -induced neurotoxicity through NMDAR, the
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present work has not yet determined whether blockade of TRPC6 may have a greater
protective effect than directly blocking NMDAR. Such an important question needs to be
addressed in future studies.
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Chapter I: Figures

Figure 1 Ischemia/Reperfusion (I/R) and OGD increased TRPC6 expression.
(A, B) Time course analysis of TRPC6 mRNA (A) and protein (B) expressions in the
ipsilateral and contralateral cortices of mice subjected to I/R. Quantitative analyses of
the changes in TRPC6 mRNA and protein levels at the indicated time points after I/R
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were determined by densitometry. Fold increases are relative to Sham (S). *P<0.01
compared to corresponding values in the contralateral cortices (n=4/group). (C) TRPC
6 protein in WT cortical neurons subjected to OGD. Immunoblotting was performed with
50 µg of total proteins and probed with antibodies to TRPC6. β-actin was used as a
loading control. Three independent experiments at each time point (n=3). *P<0.01,
compared with control groups (0 h).
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Figure 2 TRPC6 deletion attenuated I/R-induced brain infarct size and protected
neurons from OGD-induced cell death.
(A) Images of the brain sections from WT and TRPC6-/- mice 24 h after a 60 min-MCAO
that were stained with TTC. Bar graph shows the infarct volume. Infarct volume was
calculated by integration of infarct areas that were not stained by TTC for all slices of
each brain. *P<0.01 (n=6 /group). Regional cerebral blood flow (rCBF) in TRPC6-/- and
WT mice at the indicated time points before (PRE), during 60 min MCAO and 45 min
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reperfusion (n=3-4/group). rCBF was measured over the MCA territory by laser Doppler
flowmetry. Baseline rCBF measured before MCA occlusion was defined to be 100%
flow. (B) Propidium iodide (PI) staining of nuclei and cell bodies (red) and
immunocytochemical labeling of MAP2 (green) of cell body and dendrites in primary
neurons from WT and TRPC6-/- mice with or without OGD pretreatment. Scale bar, 10
µm. The small, bright condensed nuclei (< 2 µm in diameter) without stomata and
dendrites indicate dead neurons as indicated by arrows. Bar graph shows the
percentage of cell death in WT and TRPC6-/- primary neurons with or without OGD
pretreatment. *P<0.01 (n=3 independent experiments/group). In each experiment, three
wells and >100 neurons/well were counted.
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Figure 3 TRPC6 deletion protected primary cortical neurons from glutamate- or NMDAinduced neuronal death.
(A) Representative images using propidium iodide (PI) staining in WT and TRPC6-/primary neurons with glutamate (100 µM) or NMDA (50 µM) pretreatments, respectively.
The small, bright condensed nuclei (< 2 µm in diameter) (arrow) show the dying
neurons. Scale bar, 10 µm. (B and C) Cell death after glutamate and NMDA
pretreatment in WT and TRPC6-/- neurons. *P<0.01 (n=3 independent
experiments/group). In each experiment, three wells and >100 neurons/well were
counted.

36

Figure 4 TRPC6 deletion decrease OGD-induced Ca2+ influx.
(A) Ratiometric fluorescence images of Fura-2 loaded WT and TRPC6-/- primary
neurons in response to glutamate (100 µM) application with and without OGD
pretreatments. Images were taken every 10 sec during the recording. Intracellular
[Ca2+]i intensity is indicated by the ratio of 340/380 nm and encoded by pseudocolor as
shown in the color bar. (B) Traces show the time course of [Ca2+]i which was analyzed
using the Nikon live cell imaging software. Glutamate was added as indicated by an
arrow before 60 Sec. Ten neurons were sampled and analyzed in each experiment.
F/F0 is expressed as the Fura-2 fluorescence ratio 340/380 nm (F) relative to the initial
fluorescence ratio (F0) at each time point. At time 0, F/F0 is 1. (C) Bar graph shows the
mean peaks of F/F0 traces of the 4 groups. *P<0.01 (n=3 independent
experiments/group).
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Figure 5 Overexpression of TRPC6 increased glutamate-evoked Ca2+ influx in WT
cortical neurons: effects of AMPA receptor antagonist, NMDA receptor antagonist, and
Na+-free medium.
(A) AdCMV-GFP and AdCMV-TRPC6-GFP were infected WT neurons with GFP
fluorescence which are indicated as GFP in the right column. Ratiometric fluorescence
images of Fura-2 AM loaded AdCMV-GFP (control) and AdCMV-TRPC6-GFP (TRPC6
overexpression) neurons after glutamate (100 µM). Images were taken every 10 sec
during recording. [Ca2+]i was analyzed using Fura-2 as ratio of 340/380 nm and
encoded by pseudocolor as in Fig. 4. (B) AdCMV-TRPC6-GFP neurons exhibited a
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significantly higher glutamate-evoked [Ca2+]i increase compared to AdCMV-GFP control
neurons in the presence of the AMPA antagonist (10 µM CNQX). The bar graph shows
the peak of F/F0 in AdCMV-GFP and AdCMV-TRPC6-GFP neurons after glutamate.
Three neurons were collected per experiment. *P<0.01 (n=3 independent
experiments/group). (C) TRPC6-mediated Ca2+ influx was blocked by an irreversible
NMDAR channel blocker MK-801 (20 M). The bar graph shows the peaks of F/F0 in
AdCMV-GFP (control) and AdCMV-TRPC6-GFP (TRPC6 overexpression) infected
neurons treated with or without MK801 in response to glutamate (100 µM) application.
Three neurons per experiment were analyzed. n=3 independent experiments/group.
*P<0.01. (D) Glutamate-evoked increase in [Ca2+]i was significantly reduced in control
(AdCMV-GFP) and AdCMV-TRPC6-GFP neurons after Na+ was removed and replaced
by NMDG in the bath solution (Na+-free bath). The bar graph shows the peaks of F/F0
in AdCMV-GFP or AdCMV-TRPC6-GFP primary neurons treated with or without NMDG
replacement in response to glutamate. Three neurons per experiment were used. n=3
independent experiments/group. *P<0.01, #P<0.05.
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Figure 6 OGD-induced [Ca2+]i increase may be attributed to voltage-sensitive Na+
channels and AMPA receptor channels.
(A) Ca2+ influx in OGD-pretreated WT primary neurons in response to glutamate (100
µM) application in the bath containing TTX (0.1 µM) and CNQX (10 µM) to block
voltage-sensitive channels and AMPA receptors. (B) Traces show the time course of
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the intracellular [Ca2+]i. (C) The bar graph shows the peaks of F/F0 traces. Ten neurons
per experiment were analyzed. n=3 independent experiments/group. *P<0.01.
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Figure 7 A schematic drawing to show the role of TRPC6 in I/R- and ODG-induced Ca2+
influx via regulation of NMDARs.
TRPC6 expression was increased in neurons following I/R in mice brain and OGD in
primary cortical neurons. TRPC6 up-regulation following I/R and OGD induced cortical
neuronal death may in part through Na+ entry, leading to over-activation of NMDA
receptors, and causing an overload of Ca2+. Deletion of TRPC6 protects against
cerebral ischemia-induced brain damage in vivo and OGD- and excitatory neurotoxin-
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induced cell death in vitro. This protection is mediated partially through TRPC6mediated NMDA pathways.
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CHAPTER II: EFFECTS OF CHRONIC INTERMITTENT
HYPOXIA (CIH) ON BAROREFLEX CONTROL OF HEART
RATE (HR) IN MICE: AORTIC DEPRESSOR AFFERENT,
VAGAL EFFERENT, AND CENTRAL COMPONENTS

Chapter II: Introduction
Obstructive sleep apnea (OSA) is a sleep disorder that is associated with many
cardiovascular complications, such as autonomic dysfunctions, stroke and heart failure.
Recent studies have shown that this sleep disorder is caused by the repeated loss of
upper airway muscle activity, resulting in decreased oxygen saturation, and increased
CO2 pressure in the arterial blood (Young et al., 2002). In OSA patients, baroreflex
control of heart rate (HR) (baroreflex sensitivity) is decreased (Parati et al., 1997;
Bradley et al., 2003; Bonsignore et al., 2006; Monahan et al., 2006). Attenuation of
baroreflex sensitivity (BRS) is closely associated with heart failure (Thames et al., 1993;
Ford et al., 1999; La Rovere et al., 2000; Shi et al., 2000; Sabbah et al., 2012) and
hypertension (Lai et al., 2006). Dysfunction in baroreflex control of HR is considered as
an independent risk factor for sudden death (Osterziel et al., 1995; Mortara et al., 1997;
Jouven et al., 2005; Okada et al., 2010). Chronic intermittent hypoxia (CIH) has been
known as a useful model to study OSA (Gozal et al., 2001; Kline, 2010). Recent studies
observed that baroreflex control of HR is significantly reduced after CIH in SpragueDawley (SD) rats (Lai et al., 2006) and different components of the baroreflex arc are
altered in other ways (Gu et al., 2007). Because mice can be genetically manipulated,
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an understanding of the effects of CIH on multiple neural components in the baroreflex
arc in wild type mice may provide the fundamental information for future study of
treatments.
Baroreflex is the homeostatic mechanism that dynamically regulates HR and blood
pressure (BP) to adapt them to changing physiological conditions. In this homeostatic
system, the barosensitive nerves in the aortic arch and carotid sinus monitor blood
pressure. The information is delivered via the aortic depressor nerve (ADN) and the
glossopharyngeal nerve to the nucleus tractus solitarus (NTS), which is called the
afferent loop of the baroreflex arc. The NTS receives the signal and processes the
inputs in parasympathetic and sympathetic brain stem nuclei, which constitutes the
central components of baroreflex control of heart rate. The parasympathetic brain stem
nuclei are directly associated with heart through cardiac vagus nerve (Cheng and
Powley 2000, Cheng et al. 1999, 2004, Pilowsky and Goodchild, 2002; Guyenet et al.,
2006). Also, the heart itself contains a network of intracardiac ganglia to modulate the
responses of heart (Adams and Cuevas, 2004). These constitute the efferent
component of the baroreflex arc.
According to the recent studies about the baroreceptor reflex impairment following CIH
in these years (Lai, 2006; Lin, 2007 a, b; Reeves, 2006 a, b; Soukhova-O’Hare, 2006 a,
b; Gu et al., 2007), only three papers from our laboratory have studied the functional
changes and associated remodeling of baroreceptor afferent, central, and efferent
components of the reflex in Fischer 344 (F344) rats (Gu, et al. 2007; Yan et al. 2008,

45

2009). Several lines of transgenic mouse models have been used to study the effects of
renin, angiotensin II type 1 receptor, and angiotensin-converting enzyme 2 on baroreflex
function against hypertension (Merrill et al., 1996; Xia et al., 2008). Mice are useful
models for studying the underlying molecular mechanisms of baroreflex impairment
during CIH. However, CIH-induced functional alteration of the neural components at
multiple sites within the baroreflex pathway in mice is not currently known.
In the present study, we hypothesized that CIH impairs the functions of baroreceptor
afferent, central, and efferent components of the baroreflex circuitry in mice. We aimed
to determine which neural components within the baroreflex circuitry are affected, and
how these components are changed by CIH. Results of this study will help us to
understand CIH-associated functional alteration of the multiple neural components in
the baroreflex arc. This study will provide the foundation for further investigation of
potential treatments for CIH-impaired baroreflex function using murine models.

Chapter II: Materials and Methods

Animals.
Mice (C57 BL/6j, 3-4 months) were used as controls for the experiments. Procedures
were approved by the University of Central Florida Animal Care and followed the
guidelines established by the National Institutes of health.
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Intermittent Hypoxia exposure.
Animals were housed in Plexiglas chambers (30× 20× 20 in.3; Oxycycler model A44XO,
BioSpherix Instruments, Redfield, NY) in a room in which light and dark cycles were set
at 12:12 h (6:00 AM to 6:00 PM). O2 concentration in these chambers was continuously
measured by an O2 analyzer and was controlled through a gas valve outlet by a
computerized system. O2 concentrations in the chambers were programmed and
adjusted automatically. Any deviation from the desired O2 concentration was corrected
by adding pure N2 or O2 through solenoid valves. Ambient CO2 in the chambers was
periodically monitored and maintained at 0.03% by adjusting overall chamber ventilation.
Humidity was measured and maintained at 40–50%. Temperature was kept at 22–24°C.
The intermittent hypoxia (CIH) profile consisted of alternating 21% (90 s) and 10% (90
s) O2 every 6 min for 12 h during the light cycle and O2 maintained at 21% for the night
period, with an overall exposure duration of 35–50 days. The room air (RA) control
animals were housed in room air under the same conditions as CIH-exposed animals,
except that the concentration of O2 was maintained at 21% throughout the duration of
exposure.

Surgical procedure.
Mice were anesthetized and ventilated with isoflurane (2%) in 95% O2-5% CO2. Body
temperature was maintained at 37 ± 1°C with a homeostatic blanket (Harvard).
Polyethylene catheters (PE-50) were placed in the left femoral artery to monitor arterial
pressure (AP) and in both left and right femoral veins to infuse drugs [sodium
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nitroprusside (SNP), phenylephrine (PE), anesthetic agents]. The hind paw pinch
withdrawal reflex was used to assess the level of anesthesia.

Baroreflex Control of HR and Baroreceptor Afferent Function in Isoflurane-Anesthetized
Mice
Baroreflex sensitivity.
Baseline values of mean arterial blood pressure (MAP) and HR and the MAP and
chronotropic responses to sequential SNP-PE applications were measured. Arterial
blood pressure was measured with a PowerLab Data Acquisition System (PowerLab/8
SP) that was connected to a pressure transducer (iWorx/CB Sciences, BP-100). HR
was calculated from pulse pressure waves with the ratemeter function of Chart 5.2
software provided in the PowerLab System. SNP and PE (Sigma, St. Louis, MO) were
freshly prepared, diluted in 0.9% NaCl, and administered intravenously by sequential
bolus injections. SNP (30-60 µg/kg in 50-100 µl saline) was injected first, and after 30–
60 s PE (150-1,500 µg/kg in 50-200 µl saline) was then injected. These doses of SNPPE induced a fast and large depressor response followed by an increase in MAP, such
that the full range of the baroreceptor function curve could be fitted with the sigmoid
logistic function (Ma, 2002). Manipulations of MAP were completed within 2 min to limit
the extent of baroreceptor resetting. The doses of SNP and PE were selected to
produce similar changes in arterial pressure in RA and CIH rats. Baseline values of
MAP and HR were averaged from a 30-s interval before SNP injection. After SNP-PE
injections, MAP and HR returned to baseline values. HR responses to MAP changes
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induced by sequential administration of SNP and PE included two phases: tachycardic
and bradycardic responses. During the tachycardic (SNP) phase, MAP and HR changes
were measured in the time window as indicated by the open boxes shown in Figure 8,
i.e., the baseline to the nadir of MAP. During the bradycardic (PE) phase, MAP and HR
changes were measured in the time window as indicated by the shadowed boxes in
Figure 8, i.e., from the peak of HR to the nadir of HR. MAP and corresponding HR were
sampled and averaged every second. We performed separate linear regression
analyses of the HR change (ΔHR)-MAP change (ΔMAP) relationships for responses to
SNP and PE in each animal. The slope of the regression line was used as an index of
baroreflex sensitivity. The correlation coefficient r2 was used to determine the goodness
of fit. In our analyses, r2 was >0.81 for each of the animals used.
Baroreceptor afferent function.
The left aortic depressor nerve (ADN) was identified in the cervical region with a
dissecting microscope. The left ADN was carefully isolated from surrounding connective
tissue using fine glass tools to avoid injury to the nerve. The left ADN was then placed
on a bipolar platinum electrode (0.12-mm outer diameter). The ADN nerve and
electrode were covered with mineral oil. ADN activity (ADNA) was amplified (×10,000)
with the bandpass filters set between 300 and 1,000 Hz by an AC amplifier (model
1800, A-M Systems). ADNA, integrated ADNA (Int ADNA), phasic arterial pressure
(PAP), HR, ECG, and body temperature were all recorded and simultaneously
displayed on different channels of the PowerLab System. Chart 5.2 software and Sigma
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Plot 9.0 were used for data acquisition and analysis. The signal-to-noise ratio for ADNA
was >6:1 in all experiments.
The ADNA signal occurred as rhythmic bursts that were synchronized with the arterial
pulse pressure (PAP; Figure 9). The ADNA signal was integrated with a 10-ms time
constant to obtain the Int ADNA. The “ADNA silent” intervals or the “noise level”
between the ADNA bursts is shown in the small boxes in the Int ADNA signal of Figure
9. The averaged value of 30 ADNA silent intervals was used to determine the noise
level for Int ADNA. This averaged noise level was subtracted from the original Int ADNA
signal to obtain the corrected Int ADNA. The corrected Int ADNA and MAP were used to
construct baroreceptor afferent function curves. For simplicity, we use “Int ADNA” to
indicate corrected Int ADNA in the text below. The baroreceptor function curve was
calculated from data measured during the rising phase of the PE-induced AP change
starting from the nadir of the SNP-induced fall in AP to the maximum of the AP. QRS
waves of the ECG signal were used to automatically define cardiac cycles by the Chart
5.2 Macro function (arrows in Figure 9). The baroreceptor function curve was fitted by
plotting the percent change of the mean Int ADNA per cardiac cycle relative to the Int
ADNA baseline value before drug administration against MAP, using a sigmoid logistic
function (28, 37). The logistic function for Int ADNA used the mathematical expression:
Y = P1/{1 + exp[P2 (X - P3)]} + P4, where X = mean arterial pressure, Y = Int ADNA (%
baseline), P1 = maximum - minimum Int ADNA (range), P2 = slope coefficient, P3 =
mean arterial pressure at 50% of the Int ADNA range (Pmid), and P4 = maximum Int
ADNA. Pth and Psat were calculated from the third derivative of the logistic function,
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and they were expressed as Pth = P3 - (1.317/P2) and Psat = P3 + (1.317/P2). The
maximum gain or slope (Gmax) was calculated at Pmid from the first derivative of the
logistic function (Gmax=-P1 × P2/4). Approximately 100-300 datapoints measured over
60-120 s were used to construct a baroreceptorfunction curve with Sigma Plot software.
The correlation coefficient r2 was used to determine the goodness of fit. In our analysis,
r2 was > 0.95 for each animal used. Parameters of the baroreflex function curve were
averaged within groups.
HR and Blood Pressure Responses to Electrical Stimulation of Left ADN
Separate groups of mice were instrumented as described above, i.e., the left ADN was
identified, isolated, and placed on a bipolar platinum electrode (0.12-mm outer
diameter). The left ADN was then crushed at a point caudal to the electrode. The nerve
was stimulated with rectangular current pulses (50 µA, 1 ms) that were delivered to the
electrode at frequencies of 2, 5, 10, 20, 30, 40, 50, and 60 Hz from a Grass S48
Stimulator (Grass Instruments, West Warwick, RI) through an isolation unit (Grass
model PSIU 6). The duration of the stimulus train was 20 s, with 5 min allowed for
recovery between periods of stimulation. Responses to each frequency of stimulation
were measured at least twice in each experiment, with the order of changes of
frequency presentation reversed during the second round of stimulation. The responses
were repeatable. The maximal changes in HR and MAP during ADN stimulation were
measured. In addition, the time course of the HR responses calculated both as
percentage of the maximum response and as percentage of baseline was assessed.

51

The stimulationinduced changes in MAP and HR were abolished after the left AND was
crushed cranial to the electrode, confirming that the responses were reflex in nature.
HR and Blood Pressure Responses to Electrical Stimulation of Left Vagus Nerve
The right cervical vagus nerve was isolated from surrounding connective tissue with fine
glass tools and sectioned. The distal cut end of the vagus nerve was placed on a bipolar
platinum electrode and stimulated electrically with rectangular current pulses (500 µA, 1
ms) at frequencies of 2, 5, 10, 20, and 30 Hz. The data were analyzed as described for
ADN stimulation. The stimulation-induced changes in HR and AP were abolished after
the vagus nerve was crushed caudal to the electrode, confirming that the responses
were indeed due to vagal efferent activity.

Statistical Analysis.
Data are presented as means ± SE. Student’s t-tests were used to compare the
difference of baseline HR and MAP, the slopes of the regression lines, the parameters
of the baroreceptor function curves between groups, and the responses at single ADN
or vagal stimulation point. Effects of stimulation frequency and treatment (RA vs. CIH)
on HR and MAP responses were analyzed with two-way analysis of variance (ANOVA)
followed by Student-Newman-Keuls post hoc tests for determination of between- and
within-group differences. Differences were considered significant when P < 0.05.
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Chapter II: Results

CIH Does Not Alter the Baseline Values of Arterial Blood Pressure and HR
To determine whether CIH directly alters baseline MAP and HR, RA and CIH baseline
MAP and HR were measured under anesthesia. These MAP and HR values were
comparable in RA and CIH mice [n = 8 (RA), 8 (CIH); P> 0.10] (Table 1). Under SNP
and PE treatment, the MAP and HR values of RA and CIH mice were also not
significantly different [n = 8 (RA), 8 (CIH); P>0.10]. With comparable basal MAP and HR
values in the RA and CIH groups, this allowed us to compare ADNA responses to blood
pressure changes and HR responses to left ADN and vagal efferent stimulation.

CIH Significantly Decreases the Baroreflex Control of HR (Baroreflex Sensitivity)
SNP application induced hypotension that reached a similar nadir in RA and CIH mice
(RA 47±2 mmHg vs. CIH 45±1 mmHg; P>0.10). Subsequent injection of PE produced a
ramp increase in MAP that reached a similar maximum of 180±4 (RA) and 173±5 (CIH)
mmHg (P>0.10). Thus, baroreflex sensitivity could be examined over a similar range of
blood pressure changes in RA and CIH mice, as shown in Figure 3. The tachycardic
and bradycardic phases responses were fitted as separate regression lines in
representative RA and CIH mice (Fig. 3A, top and bottom, respectively). The average
slopes of the regression lines are significantly different for both tachycardic and
bradycardic phases: -0.68±0.07 (RA) vs. -0.45±0.06 (CIH) beats per minute (bpm)/
mmHg (P<0.05, n= 8; Fig. 3B, top) and -2.93±0.71 (RA) vs.-1.17±0.54 (CIH) bpm/mmHg
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(P<0.05, n= 8; Fig. 3B, bottom). Therefore, CIH significantly decreased the baroreflex
control of HR during sequential SNP-PE administrations.

CIH Increases Baroreceptor Afferent Function
ADNA was decreased in response to SNP-induced hypotension and was increased in
response to the PE-induced increase in AP (Figure 4A). Figure 4B shows representative
relationships between Int ADNA and MAP in RA and CIH mice. Compared with RA, CIH
significantly increased Gmax (Maximum Slope or Gain of the function) and the range of
ADNA response (maximum – minimum Int. ADNA) (Table 2). In addition, the response
to a MAP increase was a larger percentage of baseline activity. However, the values of
Pth, Pmid, and Psat for the baroreceptor afferent function curve did not differ
significantly between these groups. With the group means the logistic function curves
were reconstructed and were significantly different between RA vs. CIH mice (Figure
4C).

CIH Decreases Central Mediation of Baroreflex Control of HR and MAP
Electrical stimulation of the left ADN evoked frequency dependent decreases in HR and
MAP in both RA and CIH mice (Figure 5A). CIH significantly decreased the peak
bradycardic and depressor responses to stimulation (Figure 5B). Furthermore, at all
frequencies of stimulation the fall in HR developed more slowly in CIH mice than in RA
mice (Fig. 5A). Group data compiled for stimulation at a frequency of 60 Hz show that
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CIH significantly slowed the HR response (Figure 5C) and reduced the magnitude of the
decrease in HR after stimulus onset (Figure 5D; ANOVA, P<0.05).

CIH Augments Vagal Efferent Control of HR
Electrical stimulation of the right vagal efferent nerve evoked frequency-dependent
decreases in HR and MAP in both RA and CIH mice (Figure 6A). Compared to RA
mice, CIH mice significantly increased the peak magnitude of bradycardia at low
frequencies of stimulation (5 Hz) (Fig. 6B). At higher frequencies of stimulation (10 Hz),
HR and MAP responses were not significantly different between groups. Increased to
the highest frequencies of stimulation (30 Hz), HR and MAP responses were
significantly different between groups. Interestingly, the responses of HR and MAP were
not always at the same strength, such as the responses at 20 Hz.

Chapter II: Disscusion and Conclusion
Consistent with our hypothesis that CIH impairs baroreflex sensitivity and alters the
function of baroreceptor afferent, central, and vagal efferent components of the
baroreflex arc, we found that CIH caused different effects on these three components.
Specifically, CIH augmented baroreceptor afferent and vagal efferent function, but
significantly attenuated the HR response to ADN stimulation, indicating that CIH
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diminished the central mediation of baroreflex bradycardia. These findings suggest that
CIH differentially alters the different components within the baroreflex.

CIH impairs baroreflex control of HR in rats and mice: comparison.
Previous studies have demonstrated that CIH significantly impairs baroreflex control of
HR in F344 rats and C57BL/6J mice (Gu et al. 2007; Lin et al., 2007). Studies in F344
rats have found that CIH selectively impaired central mediation of the baroreflex but
augmented aortic depressor afferent and vagal efferent control of HR (Gu et al. 2007).
Further studies in F344 rats have shown that CIH reduced the number of AMPA- and
NMDA-immunoreactive neurons in nucleus ambiguus (NA) (Yan et al., 2008, 2009).
This cellular loss in the NA, one of the central autonomic components in the brain stem,
could contribute to the reduced baroreflex control of HR. On the other hand, CIH
enhanced the function of barosensitive neuron on the nucleus of the solitary tract (NTS),
another central autonomic component in the brain stem (Kolpakova et al., 2017 a, b in
preparation). Along with the previous studies, it suggested that NA is the key
component impaired by CIH in F344 rats. The anatomy study also demonstrated that
CIH significantly remodeled the structure of afferent terminal structure, vagal cardiac
axons, terminals in cardiac ganglia and cardiac principal neurons (Ai et al, 2009; Cheng,
2017).
Our rent data used the mouse model and confirmed that the baroreflex is also impaired
by CIH. CIH reduced the central mediation of baroreflex control of HR but enhanced the
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baroreflex afferent and vagal efferent function, which is consistent with the previous
finding in F344 rats. We speculate that CIH may selectively impair the NA neurons and
remodel the structure of the neural components at multiple sites within the baroreflex
arc in mice as seen in rats.

Conclusion
Our results have demonstrated that CIH significantly attenuates the central mediation of
baroreflex control of HR but augments baroreceptor afferent sensitivity and HR
responses to vagal efferent stimulation. This indicates that the central components in
the vagal baroreflex loop are the most susceptible components to CIH in rats and mice.
Within the brain stem, the nucleus of the solitary tract (NTS) and nucleus ambiggus are
the two key central components for the baroreflex arc. Previously, we have showed that
CIH reduces the nucleus ambiguus (NA) control of heart rate and induces cell death of
cardiac vagal motor neurons in the NA in rats (Yan et al. 2008, 2009), but enhances the
spike frequency of barosensitive neurons in the NTS in response to arterial pressure
elevation (Kolpakova et al. 2017a, 2017b in preparation). This indicates the damage of
the NA is the key factor for CIH-impaired baroreflex sensitivity. Thus, the NA is the
potential key target for the treatment. The future work should be aiming at the potential
treatment using genetic models as well as pharmacological tools to study the protective
effects [such as TRPC6 (Chapter 1) and SOD1 (Chapter 3)].
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Chapter II: Figures
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Figure 8 Original recordings of the heart rate (HR) responses to phasic arterial pressure
(PAP) changes induced by sequential sodium nitroprusside (SNP)-phenylephrine (PE)
administration from a room air (RA; top) mouse and a chronic intermittent hypoxia (CIH;
bottom) mouse.
Sequential SNP-PE administration included 2 phases: tachycardic and bradycardic
responses. During SNP application (tachycardic phase), changes in mean arterial blood
pressure (MAP) and HR (ΔMAP and ΔHR) were measured from the baseline to the
nadir of MAP as shown by the open boxes. During PE application (bradycardic phase),
ΔMAP and ΔHR were measured from the peak of the HR to the nadir of the HR as
shown by the shadowed boxes.
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Figure 9 Recording of PAP, aortic depressor nerve activity (Raw ADNA), integrated
ADNA (Int ADNA), and ECG.
Top: PAP. Upper middle: ADNA occurred as rhythmic bursts that were synchronized
arterial pulse pressure. Note that ADNA increases before arterial pressure increases,
because the catheter for blood pressure measurement was inserted into the femoral
artery. Lower middle: ADNA signal was integrated, using a 10-ms time constant to obtain
the Int. ADNA. The small boxes enclose silent intervals (noise level) between the ADNA
bursts. Bottom: ECG. QRS waves of the ECG signal were used to separate ADNA firing
intervals automatically with Chart 5.2 (arrows).
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Figure 10 CIH attenuates baroreflex sensitivity.
(A) Regression lines for ΔHR-ΔMAP at tachycardic (SNP) and bradycardic (PE) phases
in a representative RA and a representative CIH mice. Note that these were different
mice from those in Figure 9. (B) Average slope of the regression lines for ΔHR-ΔMAP at
the tachycardic phase [SNP: -0.69 ± 0.30 (RA), -0.22 ± 0.02 (CIH); *P<0.05] and the
bradycardic phase [PE: -1.35 ± 0.12 (RA), CIH: -0.83 ± 0.18 (CIH); *P<0.05]. (RA: n =
7/group; CIH: n=8/group.)
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Figure 11 CIH increases baroreceptor afferent function.
(A) Original recordings showing arterial pressure and ADNA (Raw ADNA and Int.
ANDA) responses to sequential intravenous injections of SNP-PE in a RA and a CIH
mouse. (B) Baroreceptor afferent function curves derived from Int ADNA responses to
sequential intravenous injections of SNP and PE in a RA and a CIH mouse. (C)
Baroreceptor afferent function curves for RA (n= 8) and CIH (n= 8) groups were
reconstructed, using the averaged parameters of logistic function curves (see Table 2).
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Figure 12 CIH attenuates central mediation of baroreflex control of HR and blood
pressure.
(A) Recordings showing HR and arterial pressure responses to electrical stimulation of
the left ADN at 2–60 Hz in a representative RA and a representative CIH mouse. (B)
ADN stimulation frequency-HR curves (left) and ADN stimulation frequency-MAP curves
(right). CIH decreases the maximal peak responses of HR and MAP. (C) Averaged ΔHR
(in % maximum) to ADN stimulation at 30 Hz. (D) Averaged ΔHR (in % maximum) to
ADN stimulation at 60 Hz. CIH significantly decreased the ΔHR (% maximum) at a given
time. †Significant difference between groups; *significant difference of the response at
the given time CIH vs. RA (student’s t test; P<0.05).

68

69

Figure 13 CIH enhances HR and MAP responses to vagal efferent stimulation.
(A) Original recordings showing HR and MAP responses to electrical stimulation of left
cervical vagus at 2–30 Hz in a RA and a CIH mouse. (B) HR responses (left) and MAP
(right) are plotted as the function of electrical stimulation frequency. CIH significantly
enhanced HR responses to vagal stimulation at low frequencies (ANOVA; P < 0.05). (C)
Averaged ΔHR (in % maximum) to ADN stimulation at 10 Hz. (D) Averaged ΔHR (%
maximum) to ADN stimulation at 30 Hz. CIH significantly increased the ΔHR (%
baseline) at a given time. †‡Significant difference between groups (†P<0.05, ‡P<0.01)
(ANOVA); *significant difference of the response at the time vs. RA (P < 0.05) (student’s
t test).

70

Chapter II: Tables
Table 1 Baseline of HR and MAP, arterial pressure response to SNP and PE.

Average HR (BPM)

MAP (mmHg)

SNP MAP (mmHg)

PE MAP (mmHg)

RA (n=8)

557.2±17.8

89.0±2.6

38.7±1.4

135.8±3.1

CIH (n=8)

545.9±11.0

89.0±1.9

42.3±1.5

139.1±2.0

Values are means ± SE for n mice. Baseline values and SNP &PE MAP were comparable in room air (RA) and
chronic intermittent hypoxia (CIH) mice.
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Table 2 Parameters defining the baroreceptor afferent (ADNA %baseline) function curve in RA and CIH mice.

r2

P1, %

P2

Gmax,
P3, mmHg

P4, %

(slope coefficient)

Pth, mmHg

Psat, mmHg

%/mmHg

RA (n=8)

0.95±0.006

298.64±17.51

0.069±0.006

93.59±3.25

305.38±15.92

40.74±0.37

73.13±2.28

114.06±4.48

CIH (n=8)

0.97±0.005

399.52±34.60

0.063±0.005

95.91±2.64

389.24±31.82

50.92±0.37

73.33±2.69

118.49±3.88

NS

<0.05

<0.05

NS

NS

P value

NS

<0.01

NS

Values are means ± SE. r2: correlation coefficient; P1, maximum - minimum Int ADNA (range); P2: slope
coefficient; P3 = mean arterial pressure at 50% of the Int ADNA range (Pmid); P4 = maximum Int ADNA; Gmax =
Maximum Slope or Gain of the function; Pth, P threshold, P3 - (1.317/P2); Psat, P saturation, P3 + (1.317/P2).
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CHAPER III: BAROREFLEX CONTROL OF HRART RATE IN
HUMAN SOD1 OVEREXPRESSION MICE: FUNCTIONAL
CHANGES OF CENTRAL AND VAGAL EFFERENT
COMPONENTS

Chaper III: Introduction
Multiple cardiovascular diseases such as diabetes, hypertension, sleep apnea and
aging (Olshan et al. 1983, Maser and Lenhard, 2005, Vinik et al. 2003, Moreira et al.
1992, Narkiewicz and Somers 2001, Kuo et al. 1999, Saint Martin et al. 2015, Fauvel et
al. 2007, Monahan 2007) are associated with autonomic dysfunctions. In particular, one
of the autonomic dysfunctions is impaired baroreflex control of heart rate (HR).
Baroreflex sensitivity (BRS) is a measure of the strength of baroreflex control of HR in
response to arterial pressure change, and it is an independent index of cardiac
autonomic functions. One of the possible causes for the impaired baroreflex sensitivity
may be due to the excessive reactive oxygen species (ROS) generation in these
diseases (Wang et al. 2010, Chan et al. 2014). Thus, antioxidant enzymes have been
proposed to be potential treatments for diabetes- and sleep apnea-induced impaired
autonomic functions (Shan et al. 2007, Carreras et al. 2015, de Souza et al, 2017).
However, the available evidence from the literature has suggested that superoxide
dismutase 1 (SOD1) overexpression can have either protective or detrimental effects on
tissues. Therefore, we need to consider whether hSOD1 overexpression in animals can
affect the neural components of the baroreflex arc in healthy animals. Only then, can we
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consider any potential benefits of SOD1 overexpression in disease-induced impairment
of the baroreflex arc. Previously, we have determined the effects of hSOD1
overexpression in transgenic mice on several physiological variables [arterial pressure
(AP), heart rate (HR), BRS, and aortic depressor nerve function] compared to controls
(Hatcher et al. 2015). These previous findings indicated that hSOD1 overexpression in
transgenic mice did not alter the values of AP, HR and baroreflex sensitivity but
enhanced aortic depressor nerve function. The baroreflex arc includes vagal aortic
depressor nerves, central components [e.g., the nucleus of the solitary tract (NTS), and
vagal motor nucleus], and vagal efferent nerves to the heart. Since hSOD1
overexpression enhances aortic depressor nerve function but maintained baroreflex
sensitivity, we hypothesized that hSOD1 overexpression may alter the central mediation
and/or vagal efferent control of HR. Indeed, SOD1 overexpression enhanced central
mediation of bradycardia (i.e., decreased heart rate) but decreased vagal efferent
control of HR. Along with our previous study, our work will provide baseline data on the
effects of the hSOD1 overexpression on the baroreflex arc. This will facilitate future
studies of the possible protective effects of overexpressed SOD1 in murine disease
models.
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Chapter III: Materials and Methods

Animals
Mice (C57BL/6J, 3-4 months) were used as controls for the transgenic Cu/Zn SOD mice
(C57B6SJL-Tg (SOD1)2 Gur/J, Jackson catalog # 002297). Procedures were approved
by the University of Central Florida Animal Care and Use Committee and followed the
guidelines established by the National Institutes of health.

Surgical Procedure
Mice were anesthetized with 3% isoflurane inhalation and maintained with 1% isoflurane
in a mixture of 95% O2 and 5% CO2 through a tracheal tube. Depth of anesthesia was
monitored by eye blink, withdrawal reflexes (toe-pinch) and fluctuations of arterial blood
pressure. Body temperature was maintained at 37 ± 1 °C with a homeostatic plate and a
rectal probe (ATC 1000; World Precision Instrument, Sarasota, FL, USA). Tapered
polyethylene catheters (PE-50) were placed in the left femoral artery to monitor arterial
pressure (AP) and in both left and right femoral veins to infuse drugs (sodium
nitroprusside (SNP), phenylephrine (PE) and anesthetic agents). Wire electrodes were
attached to the root of the legs to measure electrocardiogram (ECG). These mice were
used for assessment of AP, HR, baroreflex bradycardia (decreased HR) and
tachycardia (increased HR) as well as the cardiovascular responses to the left aortic
depressor nerve (ADN) or vagal nerve stimulation. All experiments were conducted
while the animals were maintained in the anesthetized state.
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Arterial Pressure, Heart Rate and Baroreflex Control of Heart Rate
The blood pressure catheter was connected to a blood pressure transducer (MIT0699,
AD instruments). The transducer tip was positioned near the level of the heart. Arterial
blood pressure (AP) was measured using the Powerlab Data Acquisition System
(PowerLab/8 SP). Mean arterial pressure (MAP) and heart rate were (HR) were derived
from the AP values using Chart 5 software (AD instruments). ADN activity (ADNA),
integrated ADNA (Int ADNA), phasic arterial pressure (PAP) and ECG were all recorded
and simultaneously displayed on different channels of Chart 5. The method of
sequential injection of sodium nitroprusside (SNP) and phenylephrine (PE) to decrease
and increase MAP and calculation of baroreflex sensitivity were identical to those
previously described (Gu et al. 2008 and Hatcher et al. 2016).

HR and MAP Responses to Stimulation of the Left ADN
A cervical midline incision was performed, and the trachea was cannulated with a
catheter (polyethylene-50) to facilitate ventilation in spontaneously breathing mice. The
left aortic depressor nerve (ADN) was identified in the cervical region using a dissecting
microscope. The left ADN was carefully isolated from surrounding connective tissues
with fine glass tools to avoid injury of the nerve. Then, the left ADN was placed on
miniaturized bipolar platinum electrodes (0.12 mm outer diameter). The nerve and
electrodes were soaked in mineral oil. The left ADN was then crushed at a point caudal
to the electrode. The baseline values of HR and MAP were measured 30 s prior to
stimulation. The nerve was stimulated with rectangular current pulses (3 µA, 1 ms) that
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were delivered to the electrode at frequencies of 2- 60Hz from a Grass S48 Stimulator
(Grass Instruments, West Warwick, RI) through an isolation unit (Grass model PSIU 6).
The duration of the stimulus train was 20 s, with the 3-5 min inter-train stimulus allowed
for recovery between periods of stimulation. HR and MAP responses to each frequency
of stimulation were measured at least twice in each experiment with the order of
changes of frequency reversed during the second round of stimulation. The responses
were repeatable. The maximal HR and MAP responses to electrical stimulation of the
left ADN were measured. In addition, the time course of the HR and MAP responses in
percent (%) maximum value during stimulation, that were sampled and averaged every
1.0 s interval, was assessed. The stimulation induced changes in HR and MAP were
abolished after the left AND was crushed cranial to the electrode, confirming that the
responses were reflex in nature.

HR and MAP Responses to Electrical Stimulation of the Left Cervical Vagus Nerve
The left cervical vagus nerve was carefully dissected free from surrounding structures
and was cut just caudal to the nodose ganglion. After the vagal nerve was cut, the
caudal cut end was placed on a pair of bipolar platinum hook electrodes and electrically
stimulated with a Grass Stimulator (S48). The stimuli [square wave pulses (30 μA, 1
ms) at 2-30 Hz for 20 s] were delivered with an isolation unit (ISU 6). Maximal HR and
MAP responses to electrical stimulation of the cervical vagal nerve were measured. The
data were analyzed as described for ADN stimulation. The stimulation-induced changes
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in HR and MAP were abolished after the vagus nerve was crushed caudal to the
electrode, confirming that the responses were indeed due to vagal efferent activity.

Statistical Analysis
Data are presented as means ± SE. Differences between two groups was determined
using Student’s t-tests. To compare the differences of HR and MAP curves between
C57 and SOD1 mice, two-way analysis of variance (ANOVA) with repeated measures
followed by Student-Newman-Keuls post hoc tests were used. Statistical significance
was set at P<0.05.

Chapter III: Results

MAP and HR, and Baroreflex Control of HR.
We have re-measured MAP and HR and baroreflex control of HR using different
animals and datasets available from our previous work (Hatcher et al., 2016).
Consistent with Hatcher et al., (2016), hSOD1 overexpression did not significantly alter
baseline MAP and HR (Table 3, P>0.05). In addition, SOD1 did not significantly change
the baroreflex control of HR during sequential SNP-PE administration (Figs. 14 and
15).
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SOD1 Overexpression Did Not Change HR and MAP Responses To Aortic Depressor
Nerve Stimulation.
The left aortic depressor nerve (ADN) was first identified (Fig. 16). Electrical stimulation
of the ADN evoked frequency dependent decreases in HR and MAP in SOD1 and C57
mice (Fig. 17A). There was no difference in HR reduction in response to electrical
stimulation at different frequencies between SOD1 and C57 mice (Fig. 17B). For MAP,
there was a slight but significant greater decrease in MAP at 50 Hz stimulation
frequency in SOD1 mice than C57 mice (p<0.05) (Fig. 17B) In the time course analysis
at 30 and 60 Hz, HR and MAP responses to electrical stimulation of the aortic depressor
nerve were not significantly different between two groups, further indicating that SOD1
overexpression did not change HR and MAP responses to aortic depressor nerve
stimulation.

SOD1 Overexpression decreased HR and MAP responses to vagal efferent nerve
stimulation.
Electrical stimulation of the vagal efferent nerve evoked frequency dependent
decreases in HR and MAP in both SOD1 and C57 mice (Fig. 18A). There were
significant differences in the HR and MAP depressions in responses to electrical
stimulations at different frequencies between SOD1 and C57 mice (Fig. 18B, p<0.05).
In addition, in the time course analysis for 10 and 30 Hz, HR and MAP responses to
electrical stimulation of the vagal efferent nerve were significantly different between two
groups.
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Chapter III: Discussion and Conclusion
In this study, we demonstrated that SOD1 overexpression decreased HR responses to
vagal efferent nerve stimulations but did not change HR responses to the aortic nerve
stimulation, indicating a possible enhancement of central mediation of HR responses.
Along with the previous study (Hatcher et al. 2016), we suggest that SOD1
overexpression preserves the normal BRS but may alter the functions of aortic
depressor nerve, vagal efferents and central components differently. While SOD1
overexpression enhanced aortic depressor nerve function and central mediation of
bradycardia, it decreased vagal efferent control of HR.

Central mediation of baroreflex bradycardia and vagal efferent control of HR.
Previously, we founded that the basal arterial pressure and heart rate are not changed
in hSOD1 overexpressed mice as compared to the normal control. In addition, hSOD1
overexpression did not change baroreflex control of HR. However, hSOD1
overexpression augmented aortic depressor nerve function (Hatcher et al. 2015). The
baroreflex arc includes aortic depressor nerve and vagal efferent nerves, as well as the
central components, including the nucleus tractus solitarus (NTS), nucleus ambiguus
(NA), dorsal motor nucleus of the vagus nerve (DMNX), paraventricular nucleus of the
hypothalamus (PVN), caudal ventrolateral medulla (cVLM) and rostral ventrolateral
medulla (rVLM) (Pilowsky & Goodchild, 2002; Guyenet, 2006; Andreson, 2004; Kara,
2003). Thus, we reasoned that the increased signaling from the aortic depressor
baroreceptor nerves to the brainstem is buffered by other the neural components of the
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baroreflex circuitry. i.e., hSOD1 overexpression may alter either central mediation
and/or vagal efferent control of HR. In this study, we first examined whether hSOD1
overexpression altered the HR reduction in response to aortic depressor nerve
stimulation. Our data indicate that hSOD1 overexpression did not alter baroreflex
bradycardia in response to aortic depressor nerve stimulation. Following up, we tested
whether hSOD1 overexpression altered the HR reduction in response to vagal efferent
nerve stimulation. We found that hSOD1 overexpression decreased bradycardia in
response to vagal efferent nerve stimulation. Taken together, these findings have
revealed that SOD1 overexpression may have different effects on different neural
components in the baroreflex circuitry: it increased aortic depressor nerve function and
central mediation of reflex bradycardia, but decreased the bradycardia responses to
vagal efferent stimulation.

Antioxidants in autonomic neuropathy
It has been shown that antioxidants can be used to effectively reduce hypertension,
increase vascular compliance, and improve baroreflex-mediated control of heart rate
(Nozoe et al. 2007, Yuan et al. 2012, Kawada et al. 2015, Gouty et al. 2003, Wang et al.
2002, Shargorodsky et al. 2010). Since ROS has a wide variety of necessary biological
functions, it is important to evaluate the effects of systemic application of antioxidants
on cardiac autonomic functions in an animal model without any diseases. The current
study used a transgenic mouse model expressing human Cu/ZnSOD (SOD1) at a level
roughly 3.5-fold over normal murine SOD1 expression in cortical tissue (Gurney et al.
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1994). This transgenic line was originally developed as a gene-dosage control for a
mouse model of amyotrophic lateral sclerosis (ALS) overexpressing a SOD1-G93A
mutation. The SOD1mouse line used in this study showed no signs of ALS-like
symptoms. Also, Dal Canto and Gurney (1995) demonstrated that this line of mice did
not show ALS-like symptoms, though they had very subtle changes in the anterior
portion of the anterior horn, including mild swelling of motor fibers and vacuolization of
dendrites. Functionally, there were no signs of impaired motor performance until 58
weeks of age in this line. In this study, the mice were used at a much early age (12 and
16 weeks of age) and no motor function changes were observed.
Previously, it has been shown that CIH and diabetes may reduce central mediation of
reflex bradycardia and induced cardiac vagal motor neurons death in the nucleus of
ambiguus (Gu et al. 2007, 2008; Yan et al. 2007, 2008, and 2009). Xu et al. (2004)
used this same line of mice and showed that overexpressing hSOD1 increased
resistance to oxidative stress and apoptosis of cortical neurons after exposure to
chronic intermittent hypoxia (CIH) as compared to wild-type control. Furthermore,
hSOD1 overexpression has also been shown to protect against mitochondrial
cytochrome C release and subsequent apoptosis in focal cerebral ischemia models of
stroke (Fujimura et al 2000). The current data indicate that hSOD1 overexpression did
not cause dysfunction of MAP, HR, and BRS but may increase aortic baroreceptor
nerve function and central mediation of reflex bradycardia, as well as decrease HR
response to electrical stimulation of vagal efferent nerve. At the moment, we could not
interpret the exact cellular and molecular mechanisms for such an enhancement of
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aortic depressor nerve function and central mediation as well as the reduction of vagal
efferent control of HR. It appears that overexpressing hSOD1 may have different effects
on different neural components. Thus, we propose that hSOD1treaments may very
likely have different effects on autonomic neuropathy, depending upon location of the
treatments. Whether overexpressing hSOD1 may prevent CIH and diabetes-induced
central mediation of reflex bradycardia is an interesting issue and should be tested in
the future.
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Figure 14 Original recordings of the heart rate (HR) responses to mean arterial
pressure (MAP) changes induced by sequential sodium nitroprusside (SNP)phenylephrine (PE) administration from a WT (C57; top) and a hSOD1-overexpression
(SOD1; bottom) mouse.
Sequential SNP-PE administration included 2 phases: tachycardic and bradycardic
responses. During SNP application (tachycardic phase), MAP and HR changes (ΔMAP
and ΔHR) were measured from the baseline of MAP to the nadir of MAP as shown by
the open boxes. During PE application (bradycardic phase), ΔMAP and ΔHR were
measured from the peak of the HR to the nadir of the HR as shown by the hatched
boxes.
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Figure 15 Baroreflex sensitivity in C57 and SOD1 mice.
(A) Regression lines for ΔHR-ΔMAP at tachycardic (SNP) and bradycardic (PE) phases
in a representative WT (C57) and a representative hSOD1 overexpression (SOD1)
mouse. (B) The averaged slopes of regression lines for ΔHR-ΔMAP at the tachycardic
phase [SNP: -0.66±0.12 (C57), -0.86±0.16 (SOD1); P>0.05] and the bradycardic phase
in C 57 and SOD1 mice [PE: -3.52 ± 1.30 (C57), -3.91±0.94 (SOD1); P>0.05].
n=8/group.
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Figure 16 Recording of phasic arterial pressure (PAP), aortic depressor nerve activity
(Raw ADNA), integrated ADNA (Int ADNA), and ECG.
Top: PAP. Upper middle: ADNA occurred as rhythmic bursts that were synchronized
PAP. Note that ADNA increases before AP increases. This is because the catheter for
PAP measurement was inserted into the femoral artery whereas ADNA was measured
from ADN that innervates the aortic arch. Lower middle: ADNA signal was integrated,
using a 10-ms time constant to obtain the Int ADNA curve. The small boxes enclose
silent intervals (noise level) between the ADNA bursts that was used as the basal
activity. Bottom: ECG. QRS waves of the ECG signal were used to separate ADNA
firing intervals automatically with Chart 5.2 (arrows).
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Figure 17 Central mediation of baroreflex bradycardia and blood pressure.
(A) Original recordings of heart rate (HR) depression following stimulation of the aortic
depressor nerve (ADN) at 3µA, 1-ms pulses over a 20-s train stimulus in C57 and SOD1
mice. Representative figures above encompass the mid-range frequencies between 5
Hz and 60 Hz. (B) Electrical stimulation of the left aortic depressor nerve (ADN) evoked
frequency dependent decreases in HR and MAP in both C57 and SOD1 mice. However,
they were not significantly different (P>0.05). (C) The time courses of HR depression in
response to electrical stimulation at 30 and 60 Hz were not different between SOD1 and
C57 control (P>0.05).
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Figure 18 HR and MAP responses to vagal efferent stimulation.
(A) Original recordings of heart rate (HR) depression following stimulation of the left
cervical vagus nerve at 30µA, 1-ms bursts over a 20-s train stimulus in C57 and SOD1
mice. Representative figures above encompass the mid-range frequencies between 30
Hz and 5 Hz. (B) Electrical stimulation of the left cervical vagus nerve evoked frequency
dependent decreases in HR in both SOD1 and C57 mice. They were significantly
different (P<0.05). (C) The time courses of HR depression in response to electrical
stimulation at 10 and 30Hz were significantly different between SOD1 and C57 control
(P>0.05).
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Chapter III: Tables
Table 3 Baseline of MAP and HR in C57 and SOD1 mice.
Average HR (BPM)

MAP (mmHg)

C57 (n=8)

548.15±9.76

86.15±2.77

SOD1 (n=8)

531.78±15.58

86.91±15.58
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CONCLUSION
In this dissertation, three independent projects have been completed as introduced
below. Though independent, they follow the common theme. i.e., how do ischemia &
OGD, CIH, and hSOD1 affect the central and peripheral nervous system? Can deletion
of TRPC6 or hSOD1 overexpression protect against diseases-orientated neural
damages and dysfunctions?
For the first project, we have demonstrated that TRPC6 expression was
increased in the brain tissues in the I/R animal model and OGD-treated cortical neurons
in culture. In addition, deletion of TRPC6 protected I/R-induced brain damage and
OGD-induced neuronal death. Furthermore, deletion of TRPC6 could also protect
neurons against excitatory neurotoxin (glutamate or NMDA)-induced cell death. To
determine the cellular and molecular mechanism for OGD-induced neuronal death,
OGD was found to increase, but deletion of TRPC6 reduced glutamate-evoked Ca2+
entry. TRPC6 overexpression increased glutamate-evoked Ca2+ entry in the presence of
the AMPA blocker, indicating TRPC6-incrased Ca2+ entry could be independent of
AMPA receptor channels. In the presence of the NMDA receptor antagonist MK801, the
increased glutamate-evoked Ca2+ entry in TRPC6 overexpressed neurons was largely
reduced, indicating that NMDA receptors were involved. To assess whether Na +
contributed to the TRPC6-enhaced Ca2+ influx, we found that glutamate-evoked Ca2+
entry in TRPC6 overexpressed neurons was largely reduced in Na+-free bath, indicating
that Na+ entry was required for TRPC6-mediated Ca2+ influx. Finally, we found that
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glutamate-evoked Ca2+ entry was reduced but not completely abolished in OGD-treated
WT neurons after blockade of voltage sensitive Na+ channels and AMPA receptor
channels. We postulate that TRPC6 channels, as well as other channels (e.g., voltagesensitive Na+ channels), may contribute to TRPC6-mediated Ca2+ influx, at least in part,
through NMDA receptor channels. Therefore, the present data have demonstrated that
overexpression of TRPC6 may contribute to neuronal death partially through Na + entry,
leading to activation of NMDA receptors, thus causing an overload of Ca 2+.
Since TRPC6 channels are voltage-independent and are not involved in the major
neurotransmission (Dietrich and Gudermann, 2014), pharmacologic interventions
targeting at TRPC6 may potentially have fewer side effects than direct blockade of
NMDAR. Though this study has provided a potential mechanism for theTRPC6 deletion
protection against Ca2+ -induced neurotoxicity through NMDAR, the present work has
not yet determined whether blockade of TRPC6 may have a greater protective effect
than directly blocking NMDAR. Such an important question needs to be addressed in
future studies.
For the second Project, we hypothesized that CIH would alter the baroreflex
sensitivity as well as the function of baroreceptor afferent, central, and vagal efferent
components within the baroreflex arc in the mouse model. Consistent with our
hypothesis, we found that CIH decreased baroreflex sensitivity and differentially altered
these three neural components: aortic baroreceptor function and vagal efferent control
of the heart rate were significantly increased, but the central mediation of bradycardia
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was significantly decreased. Since CIH is well-established model for studying OSA
(Gozal et al., 2001; Kline, 2010), our study underlies a neural mechanism for the
understanding of sleep apnea-impaired baroreflex sensitivity. In addition, it provides the
foundation for the future study of the potential treatment to protect CIH-induced
baroreflex impairment using the murine models.
For the third Project: In this study, we demonstrated that SOD1
overexpression decreased HR responses to vagal efferent nerve stimulations, but did
not change HR responses to the aortic nerve stimulation, indicating a possible
enhancement of central mediation of HR. Along with the previous study (Hatcher et al.,
2016), we suggest that SOD1 overexpression preserves the normal BRS, but may alter
the functions of aortic depressor nerve, vagal efferent, and central components
differently. While SOD1 overexpression enhanced aortic depressor nerve function and
central mediation of bradycardia, it decreased vagal efferent control of HR.
Previously, it has been shown that the major effect of CIH and diabetes is the
impairment of central mediation of bradycardia and the death of cardiac vagal motor
neurons in the nucleus of ambiguus in the brainstem (Gu et al., 2007, 2008; Yan et al.,
2008, 2009a,b). Xu et al. used this exact same line of mice and showed that
overexpressing hSOD1 increased resistance to oxidative stress and apoptosis of
cortical neurons after exposure to CIH as compared to wild-type control. Furthermore,
hSOD1 overexpression has also been shown to protect against mitochondrial
cytochrome C release and subsequent apoptosis in focal cerebral ischemia models of
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stroke (Fujimura et al., 2000). Whether overexpressing hSOD1 may prevent CIH and
diabetes-induced central mediation of reflex bradycardia and protect against cardiac
motor neuron death in the brainstem is an interesting issue and should be tested in the
future. Finally, whether hSOD1 may protect stroke and OGD-induced neuronal death is
an interesting issue and should be studied in the future.
Nervous system is a complicate system that transmit signals between different parts
of body. Nervous system consists of two main parts, the central nervous system (CNS)
and the peripheral nervous system (PNS). The CNS contains the brain and spinal cord.
The PNS consists mainly of nerves that connect the CNS to every other part of the
body. Neurons are non-dividing cells with highly demand of energy. Therefore, oxygen,
as the source of energy, is very important for the nervous system. Overall, this study will
help us to understand how lacking of oxygen affects the nervous system by different
mechanisms and TRPC6 or SOD1 could be the potential target to study the
neuroprotective effects.
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